var title_f21_48_22272="Garden type III hip fracture";
var content_f21_48_22272=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 494px\">",
"   <div class=\"ttl\">",
"    Garden type III hip fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 474px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type III fractures have marked angulation, but usually minimal to no proximal translation of the shaft.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baumgaertner MR, Higgins TF. Femoral neck fractures. In: Rockwood and Green's Fractures in Adults, 5th ed, Bucholz RW, Heckman JD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2002. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22272=[""].join("\n");
var outline_f21_48_22272=null;
var title_f21_48_22273="Pigmented scar in Cushings";
var content_f21_48_22273=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F62900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F62900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pigmented scar in Cushing's syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    47-year-old man with Cushing's disease who has a pigmented surgical scar from a right adrenalectomy, which did not cure the ACTH excess. Another scar (not seen) from a shrapnel wound received years before the onset of Cushing's disease is nonpigmented.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David N Orth, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22273=[""].join("\n");
var outline_f21_48_22273=null;
var title_f21_48_22274="Bile duct injury during laparoscopic cholecystectomy";
var content_f21_48_22274=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bile duct injury during laparoscopic cholecystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 418px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The common bile duct is mistaken for the cystic duct and transected. A variable extent of the extrahepatic biliary tree is resected with the gallbladder. The right hepatic artery, in background, is also often injured.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn with permission from: Branum, G, Schmidt, C, Baillie, J, et al. Management of major biliary complications after laparoscopic cholecystectomy. Ann Surg 1993; 217:532. Copyright &copy; 1993 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22274=[""].join("\n");
var outline_f21_48_22274=null;
var title_f21_48_22275="SCIT administration form";
var content_f21_48_22275=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F61006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F61006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 653px\">",
"   <div class=\"ttl\">",
"    Allergen immunotherapy administration form",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 633px; height: 791px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     v/v: volume/volume.",
"     <br>",
"      *",
"      <strong>",
"       Health screen",
"      </strong>",
"      refers to either a written or verbal interview of the patient prior to the administration of the allergy injection regarding the presence of increased asthma symptoms or symptoms of respiratory track infection, beta-blocker use, change in health status (including pregnancy), or adverse reaction to previous infection. A \"yes\" answer to this health screen may require further evaluation.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       <strong>",
"        Antihistimine use",
"       </strong>",
"       : To improve consistency in interpretation of reactions it should be noted if the patient has taken an antihistamine on injection days. Clinician may also request that antihistamines be taken consistently on injection days (recommended? Y N ).",
"       <br>",
"        &Delta;",
"        <strong>",
"         Reaction",
"        </strong>",
"        : Refers to either immediate or delayed systemic or local reactions. Local reactions (noted as LR) can be reported in millimeters as the longest diameter of wheal and erythema. The details of the symptoms and treatment of a systemic reaction (noted as SR) would be recorded elsewhere in the medical record.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Cox L, Nelson H, Lockey R. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 2011; 127(1 Supp):S1. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22275=[""].join("\n");
var outline_f21_48_22275=null;
var title_f21_48_22276="Sand bronchogram CXR";
var content_f21_48_22276=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sand tracheobronchogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Postmortem chest radiograph from a surfer shows high attenuation material outlining the tracheobronchial tree.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22276=[""].join("\n");
var outline_f21_48_22276=null;
var title_f21_48_22277="Carmustine: Patient drug information";
var content_f21_48_22277=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Carmustine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/39/33399?source=see_link\">",
"     see \"Carmustine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/17/12566?source=see_link\">",
"     see \"Carmustine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F146512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      BiCNU&reg;;",
"     </li>",
"     <li>",
"      Gliadel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F146513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      BiCNU&reg;;",
"     </li>",
"     <li>",
"      Gliadel Wafer&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700767",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause very bad lung problems. People getting a large total dose for all treatments have a greater chance of lung problems. Call your doctor right away if you have trouble breathing. Children may have lung problems many years after getting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700794",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause tissue damage if the drug leaks from the vein. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3450166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used before bone marrow or stem cell transplant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Wafer (implant):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691761",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat brain cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to carmustine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701046",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3860450",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing and low blood pressure can happen if the shot is given too fast.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Wafer (implant):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696041",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is placed in the brain during surgery.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11180 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-FB51BAF4EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22277=[""].join("\n");
var outline_f21_48_22277=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146512\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146513\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021272\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021274\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021273\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021278\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021279\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021281\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021276\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021283\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/39/33399?source=related_link\">",
"      Carmustine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/17/12566?source=related_link\">",
"      Carmustine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_48_22278="Epidemiology of varicella-zoster virus infection: Chickenpox";
var content_f21_48_22278=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology of varicella-zoster virus infection: Chickenpox",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22278/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22278/contributors\">",
"     Mary A Albrecht, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22278/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22278/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22278/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22278/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/48/22278/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varicella-zoster virus (VZV) infection causes two clinically distinct forms of disease: varicella (chickenpox) and herpes zoster (shingles). Primary VZV infection results in the diffuse vesicular rash of varicella, or chickenpox.",
"   </p>",
"   <p>",
"    The epidemiology of varicella has changed dramatically since the introduction of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    in 1995. In the United States, routine childhood immunization has reduced disease incidence, complications, hospital admissions, and deaths in children and in the general population, indicating strong herd immunity. Similar immunization programs have been adopted by several other countries, including Uruguay, Germany, Taiwan, Canada, and Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will address the morbidity and mortality of varicella infection prior to and after immunization. The clinical manifestations and management of varicella are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33480?source=see_link\">",
"     \"Clinical features of varicella-zoster virus infection: Chickenpox\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23110?source=see_link\">",
"     \"Treatment of varicella-zoster virus infection: Chickenpox\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37289?source=see_link\">",
"     \"Prevention of varicella-zoster virus infection: Chickenpox\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/28/32200?source=see_link\">",
"     \"Prevention and control of varicella in hospitals\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33225?source=see_link\">",
"     \"Varicella-zoster virus infection in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY OF VARICELLA PRIOR TO VACCINE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Incidence of varicella",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varicella occurs throughout the year in temperate regions, but the incidence typically peaks in the months of March through May [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/2\">",
"     2",
"    </a>",
"    ]. According to national seroprevalence data from the prevaccine era, greater than 95 percent of persons in the United States acquired varicella before 20 years of age, and fewer than 2 percent of adults were susceptible to infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. Prior to 1995 the Centers for Disease Control and Prevention (CDC) estimated the yearly incidence of chickenpox in the United States at approximately four million cases, with nearly 11,000 admissions and 100 deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A chart review of over 250,000 members of a health maintenance organization (HMO) was conducted from 1990 to 1992 to assess the epidemiology of varicella and its complications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/8\">",
"     8",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A total of 5686 potential incident cases in this HMO population were identified during this period; using age-specific predictive values, the estimated number of incident cases was 4884 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Seventy-six percent of cases occurred in persons less than 10 years of age. The incidence rates per 100,000 person-years in each age group were as follow: 5234 for ages 0 to 4 years; 4132 for ages 5 to 9 years; 1404 for ages 10 to 14 years; 610 for ages 15 to 19 years; and 175 for ages &gt;20 years [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/8\">",
"       8",
"      </a>",
"      ]. These rates continued to decline for older age groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In tropical countries, varicella occurs mainly among young adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/9\">",
"     9",
"    </a>",
"    ]. Several studies have confirmed primary VZV infections in these patients following intense exposure to cases in military installations, hospitals, and day care centers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/3,10-12\">",
"     3,10-12",
"    </a>",
"    ]. Seroepidemiologic surveys have confirmed that &gt;20 percent of military recruits enlisting from outside the 50 US states were susceptible to VZV [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following studies illustrate the high overall attack rates that can be seen in susceptible populations in military and school settings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/11,13\">",
"     11,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An epidemiologic investigation of two varicella outbreaks in a military training center documented that 42 percent of 810 adult recruits from Puerto Rico were seronegative for VZV; there was an overall attack rate of 30 percent in the initial varicella outbreak (estimated to be 71 percent in susceptible individuals) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a 2004 varicella school outbreak reported in China, 138 of 1407 (9.8 percent) of students developed primary varicella [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/13\">",
"       13",
"      </a>",
"      ]. Many of these children had not been vaccinated, since immunization was not required.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Varicella-related hospitalizations and mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although children were most commonly affected by varicella, adults and infants less than one year of age were overrepresented among those who developed complicated disease, with high rates of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. For example, adults over the age of 20 years accounted for less than 5 percent of varicella cases but 55 percent of varicella-related deaths (CDC unpublished data 1997) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/17\">",
"     17",
"    </a>",
"    ]. In another study, adults with chickenpox had a 25-fold higher risk of complications compared to children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/18\">",
"     18",
"    </a>",
"    ]. A review of age-specific data for varicella and encephalitis in the United States from 1972 to 1978 demonstrated that persons &gt;20 years of age accounted for fewer than two percent of varicella cases but 12 and 28 percent of varicella encephalitis and deaths, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The specific types of complications among patients with varicella also tend to vary by age, with bacterial infections occurring in most children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/19\">",
"     19",
"    </a>",
"    ] and pneumonitis being more common in adults. A review of 613 varicella-related hospital admissions in England from 1968 through 1993 demonstrated that 23 percent of adults developed varicella pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/19\">",
"     19",
"    </a>",
"    ]. Furthermore, the risk of pneumonitis was six times higher in smokers than nonsmokers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY OF DISEASE AFTER INTRODUCTION OF VARICELLA VACCINE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Incidence of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Varicella Activity Surveillance Project (VASP) was established in 1995 as a cooperative agreement between the Centers for Disease Control and Prevention and two cities in the United States (Antelope Valley, CA and Philadelphia, PA) to monitor disease incidence after the introduction of vaccine. At the start of the national varicella vaccination program, the Advisory Committee on Immunization Practices (ACIP) recommended one dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    for children 12 to 18 months of age, older susceptible children (19 months of age through 12 years of age), and high-risk groups [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14822?source=see_link\">",
"     \"Measles-mumps-rubella vaccination in high risk adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This recommendation was followed by substantial declines in the incidence of varicella and related hospitalizations within the first five years of the vaccination program; in three surveillance sites, the incidence of varicella declined by greater than 70 percent from 1995 to 2000 with vaccination rates ranging from 74 to 84 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/20\">",
"     20",
"    </a>",
"    ]. Further follow-up surveillance confirmed and extended these original findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      By 2005, overall varicella incidence in active surveillance sites had declined by 90 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/21\">",
"       21",
"      </a>",
"      ]. This decline in incidence occurred in the context of rapid uptake of vaccination coverage among young children (&gt;92 percent) supplemented by catch-up vaccination among older children.",
"     </li>",
"     <li>",
"      In a Connecticut surveillance program, the number of cases of varicella plateaued from 2001 to 2005 with an increasing number of cases occurring in children who were previously immunized with only one dose of vaccine. Notably, disease that did occur was milder amongst vaccinated children than unvaccinated children [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A similar observation of milder disease in vaccinated adults has also been reported in a 10-year study of more than 17,000 patients with varicella [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/23\">",
"       23",
"      </a>",
"      ]. Adults had a twofold (95% CI 1.8-2.3) higher risk of developing a complication and a sixfold (95% CI 4.0-9.7) higher risk of being hospitalized than children. Adolescents had illness severity intermediate between the severity in children and adults.",
"     </li>",
"     <li>",
"      In this same study [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/23\">",
"       23",
"      </a>",
"      ], age-specific incidence rates significantly declined for both children and adults; among children 0 to 14 years of age, the incidence declined by 90 percent, while in adults the incidence declined by 74 percent, despite low rates of vaccination. These findings highlight the benefits of \"herd immunity\"; this term refers to protection against infection that occurs indirectly for unvaccinated persons when others in the community are immunized.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further refinement of the vaccination program occurred in 2006, when the ACIP recommended a second dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    because of a number of varicella outbreaks occurring in highly vaccinated populations of schoolchildren [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/24\">",
"     24",
"    </a>",
"    ]. Continued monitoring will be necessary to see if any additional gains are made in decreasing the incidence of varicella.",
"   </p>",
"   <p>",
"    These aggregate data also support the use of vaccine in individuals who have been exposed to varicella. In one study, 68 percent of the adults had been exposed in the household [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/23\">",
"     23",
"    </a>",
"    ]. Post-exposure prophylaxis with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    can prevent or modify disease if given between three and five days of exposure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37289?source=see_link\">",
"     \"Prevention of varicella-zoster virus infection: Chickenpox\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Outbreaks",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of varicella outbreaks (defined as &ge;5 varicella cases epidemiologically linked to a common setting that occurred within one incubation period) have significantly decreased in number, size, and duration with the introduction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The number of outbreaks declined from 236 in the period from 1995 to 1998 to 46 in the period from 2002 to 2005",
"     </li>",
"     <li>",
"      The median number of cases per outbreak decreased from 15 to 9",
"     </li>",
"     <li>",
"      The duration of these outbreaks declined from 45 to 30 days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Varicella-related hospitalizations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following implementation of the US",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    program in 1995, rates of varicella-related hospitalizations and complications have significantly decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/20,26,27\">",
"     20,26,27",
"    </a>",
"    ]. Data from the Varicella Activity Surveillance Project were used to compare rates of hospitalization and rates of complications among patients hospitalized with varicella from 1995 to 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/26\">",
"     26",
"    </a>",
"    ]. For this project, the vaccination periods were defined as early (1995 to 1998) middle (1999 to 2001) and late (2002 to 2005). The study found the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A total of 26,290 varicella cases were reported from 1995 to 2005. Of these cases, 170 patients (6.47 per 1000 varicella cases) required hospitalization.",
"     </li>",
"     <li>",
"      Decreases in varicella-related hospitalization rates occurred in both older and younger age groups from the early to combined",
"      <span class=\"nowrap\">",
"       middle/late",
"      </span>",
"      periods: among those &lt;20 years of age, rates decreased by 77 percent; among adults &gt;20 years of age, rates decreased by 60 percent.",
"     </li>",
"     <li>",
"      Logistic regression analyses demonstrated that risk of hospitalization was independently associated with being &lt;5 or &gt;15 years of age, not being vaccinated, and being immunocompromised. Those &lt;1 year of age and &gt;20 years of age had the highest risk of varicella-related hospitalization (adjusted ORs 7.0 [95% CI 4.1-12.1] and 7.6 [95% CI 4.5-12.6], respectively).",
"     </li>",
"     <li>",
"      The rate of complications during the early vaccination period decreased by 70 to 90 percent to the",
"      <span class=\"nowrap\">",
"       middle/later",
"      </span>",
"      vaccination periods. Most of these complications were skin and soft tissue infections and pneumonitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of note, most of these hospitalizations were preventable through implementation of existing vaccination policy recommendations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Overall mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;National death records from 1990 to 2001 were reviewed to assess the effect of the vaccination program on mortality associated with varicella infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/28\">",
"     28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate of death due to varicella fluctuated from 1990 through 1998 and then declined sharply.",
"     </li>",
"     <li>",
"      This decline was observed in all age groups under 50 years, with the greatest reduction (92 percent) among children one to four years of age.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overall declines in mortality have also been noted elsewhere; in one surveillance system in Massachusetts between 1998 and 2003, the overall varicella incidence declined by 79 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/21\">",
"     21",
"    </a>",
"    ]; for deaths in which varicella was listed as the underlying cause, rates of mortality decreased by 67 percent from an annual average of 105 deaths during 1990 to 1994 to 35 deaths during 1999 to 2001.",
"   </p>",
"   <p>",
"    While there has been a substantial decline in varicella-related deaths since vaccine licensure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/28\">",
"     28",
"    </a>",
"    ], the CDC surveillance program reported six varicella-related deaths in 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/29\">",
"     29",
"    </a>",
"    ]; five of these deaths occurred in adults aged 23 to 78 years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Childhood mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately two years after the introduction of vaccine, varicella-related deaths were still being reported. A review of varicella-related deaths in children in the United States from 1997 attempted to identify factors associated with poor outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ninety percent of children who died did not have identifiable risk factors for severe varicella.",
"     </li>",
"     <li>",
"      The most frequent varicella-related complications in children were secondary bacterial infections and pneumonia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Adult mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varicella remains a more severe disease among adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/20,31\">",
"     20,31",
"    </a>",
"    ], although incidence rates and morbidity are declining in the era of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     FUTURE CONCERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because increasing use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    will lead to an expected decrease in circulating wild-type VZV, unimmunized children may acquire infection at an older age, when they are more susceptible to severe infection. Mathematical models predict that if immunization rates in children are &gt;90 percent, a greater proportion of varicella infections will occur at older ages; however, overall disease burden will decline [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22278/abstract/22\">",
"     22",
"    </a>",
"    ]. This emphasizes the need for high levels of immunization among children to prevent late-onset disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The epidemiology of varicella has been changed dramatically since the US introduction of the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"       varicella vaccine",
"      </a>",
"      in 1995. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prior to 1995 the Centers for Disease Control and Prevention (CDC) estimated the yearly incidence of chickenpox in the United States at approximately four million cases with nearly 11,000 admissions and 100 deaths. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology of varicella prior to vaccine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although children were most commonly affected by varicella, adults and infants less than one year of age were overrepresented among those who developed complicated disease with high rates of mortality. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Varicella-related hospitalizations and mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One decade after the introduction of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"       varicella vaccine",
"      </a>",
"      , overall varicella incidence in active surveillance sites had declined by 90 percent. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology of disease after introduction of varicella vaccine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The number and size of outbreaks have also decreased since the initiation of the vaccination initiative in the United States. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Outbreaks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The rate of complications from varicella infection have declined dramatically after introduction of vaccine; most complications were skin and soft tissue infections and pneumonitis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Varicella-related hospitalizations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/1\">",
"      Heininger U, Seward JF. Varicella. Lancet 2006; 368:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/2\">",
"      Straus SE, Ostrove JM, Inchausp&eacute; G, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/3\">",
"      Kelley PW, Petruccelli BP, Stehr-Green P, et al. The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits. JAMA 1991; 266:2724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/4\">",
"      Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis 1992; 166 Suppl 1:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/5\">",
"      Preblud SR, Orenstein WA, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis 1984; 3:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/6\">",
"      Seward JF, Zhang JX, Maupin TJ, et al. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA 2004; 292:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/7\">",
"      Centers for Disease Control and Prevention (CDC). Decline in annual incidence of varicella--selected states, 1990-2001. MMWR Morb Mortal Wkly Rep 2003; 52:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/8\">",
"      Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995; 172:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/9\">",
"      Merrett P, Schwartzman K, Rivest P, Greenaway C. Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis. Clin Infect Dis 2007; 44:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/10\">",
"      Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996; 10:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/11\">",
"      Longfield JN, Winn RE, Gibson RL, et al. Varicella outbreaks in Army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics. Arch Intern Med 1990; 150:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/12\">",
"      Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993; 83:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/13\">",
"      Ma H, Fontaine R, Centers for Disease Control and Prevention (CDC). Varicella outbreak among primary school students--Beijing, China, 2004. MMWR Morb Mortal Wkly Rep 2006; 55 Suppl 1:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/14\">",
"      Centers for Disease Control and Prevention (CDC). Recommended childhood immunization schedule--United States, January-June 1996. MMWR Morb Mortal Wkly Rep 1996; 44:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/15\">",
"      Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981; 68:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/16\">",
"      Centers for Disease Control (CDC). Varicella-zoster immune globulin for the prevention of chickenpox. MMWR Morb Mortal Wkly Rep 1984; 33:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/17\">",
"      Dits H, Frans E, Wilmer A, et al. Varicella-zoster virus infection associated with acute liver failure. Clin Infect Dis 1998; 27:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/18\">",
"      Guess HA, Broughton DD, Melton LJ 3rd, Kurland LT. Chickenpox hospitalizations among residents of Olmsted County, Minnesota, 1962 through 1981. A population-based study. Am J Dis Child 1984; 138:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/19\">",
"      Bovill B, Bannister B. Review of 26 years' hospital admissions for chickenpox in North London. J Infect 1998; 36 Suppl 1:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/20\">",
"      Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/21\">",
"      Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites--United States, 1995-2005. J Infect Dis 2008; 197 Suppl 2:S71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/22\">",
"      Sosa LE, Hadler JL. Epidemiology of varicella in Connecticut, 2001-2005. J Infect Dis 2008; 197 Suppl 2:S90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/23\">",
"      Marin M, Watson TL, Chaves SS, et al. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 2008; 197 Suppl 2:S94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/24\">",
"      Marin M, G&uuml;ris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/25\">",
"      Civen R, Lopez AS, Zhang J, et al. Varicella outbreak epidemiology in an active surveillance site, 1995-2005. J Infect Dis 2008; 197 Suppl 2:S114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/26\">",
"      Reynolds MA, Watson BM, Plott-Adams KK, et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. J Infect Dis 2008; 197 Suppl 2:S120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/27\">",
"      Zhou F, Harpaz R, Jumaan AO, et al. Impact of varicella vaccination on health care utilization. JAMA 2005; 294:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/28\">",
"      Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/29\">",
"      Centers for Disease Control: Summary of Notifiable Diseases--United States. MMWR Morb Mortal Wkly Rep 2009; 56:1-94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/30\">",
"      Centers for Disease Control and Prevention (CDC). Varicella-related deaths among children--United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 47:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22278/abstract/31\">",
"      Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000; 182:383.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8304 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-190.92.87.115-0E8DCFA2F5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22278=[""].join("\n");
var outline_f21_48_22278=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY OF VARICELLA PRIOR TO VACCINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Incidence of varicella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Varicella-related hospitalizations and mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY OF DISEASE AFTER INTRODUCTION OF VARICELLA VACCINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Incidence of infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Outbreaks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Varicella-related hospitalizations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Overall mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Childhood mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Adult mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      FUTURE CONCERNS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33480?source=related_link\">",
"      Clinical features of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14822?source=related_link\">",
"      Measles-mumps-rubella vaccination in high risk adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/28/32200?source=related_link\">",
"      Prevention and control of varicella in hospitals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37289?source=related_link\">",
"      Prevention of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23110?source=related_link\">",
"      Treatment of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33225?source=related_link\">",
"      Varicella-zoster virus infection in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_48_22279="Overview of the treatment of malabsorption";
var content_f21_48_22279=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the treatment of malabsorption",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Joel B Mason, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Vladan Milovic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Timothy O Lipman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22279/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/48/22279/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malabsorption refers to impaired absorption of nutrients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/1\">",
"     1",
"    </a>",
"    ]. It can result from congenital defects in the membrane transport systems of the small intestinal epithelium (primary malabsorption) or from acquired defects in the epithelial absorptive surface (secondary malabsorption). Another factor that can interfere with nutrient absorption is maldigestion, which is due to impaired digestion of nutrients within the intestinal lumen or at the terminal digestive site of the brush border membrane of mucosal epithelial cells.",
"   </p>",
"   <p>",
"    Although malabsorption and maldigestion are pathophysiologically different, the processes underlying digestion and absorption are interdependent, so that in clinical practice, the term malabsorption has come to denote derangements in either process.",
"   </p>",
"   <p>",
"    This topic review will provide an overview of the treatment of malabsorption. Issues that are relevant to specific diseases (eg, pancreatic insufficiency, celiac disease, and short bowel syndrome) are discussed in detail in the appropriate topic reviews. The clinical manifestations, diagnosis, and pathophysiology of malabsorption are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=see_link\">",
"     \"Clinical features and diagnosis of malabsorption\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/50/41765?source=see_link\">",
"     \"Mechanisms of nutrient absorption and malabsorption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NUTRIENT PROCESSING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three steps are required for normal nutrient absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Luminal events (referred to as the \"Luminal\" phase)",
"     </li>",
"     <li>",
"      Processing at the brush border and absorption into the intestinal mucosa (referred to as the \"Absorptive\" or \"Mucosal\" phase)",
"     </li>",
"     <li>",
"      Processing within the enterocyte and transport into the circulation (referred to as the \"Postabsorptive\" or \"Processing\" phase)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Malabsorption can result from defects in any of these three phases (",
"    <a class=\"graphic graphic_table graphicRef54743 \" href=\"UTD.htm?5/6/5229\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/3\">",
"     3",
"    </a>",
"    ]. Furthermore, one or more mechanisms may exist concurrently. Thus, while the clinical sequelae may be the same, the underlying pathophysiology and treatment may be different.",
"   </p>",
"   <p>",
"    Malabsorption either may be global or partial (isolated). Global malabsorption results from diseases associated with either diffuse mucosal involvement or a reduced absorptive surface. An example is celiac sprue in which diffuse mucosal disease can lead to impaired absorption of almost all nutrients. Partial or isolated malabsorption results from diseases that interfere with the absorption of specific nutrients. An example is pernicious anemia, a disease that leads to defective cobalamin (vitamin B12) absorption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PRINCIPLES OF MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three major principles underlying the management of patients with malabsorption and maldigestion, and appropriate care of such patients in the majority of cases necessitates that each of these three are addressed: (1) identification and treatment of the underlying disease, (2) treatment of the diarrhea that often accompanies these disorders, and (3) identification and correction of nutritional deficits.",
"   </p>",
"   <p>",
"    The first principle is critical because many diseases may lead to malabsorption (",
"    <a class=\"graphic graphic_table graphicRef54743 \" href=\"UTD.htm?5/6/5229\">",
"     table 1",
"    </a>",
"    ). As a result, an exact diagnosis is essential in the design of a successful therapeutic regimen.",
"   </p>",
"   <p>",
"    It is also critical to firmly establish the presence of malabsorption before proceeding with treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=see_link\">",
"     \"Clinical features and diagnosis of malabsorption\"",
"    </a>",
"    .) This may seem obvious but it is a principle that is all too frequently ignored. As an example, chronic diarrhea that follows a sizeable small intestinal resection is not invariably due to malabsorption; in many cases it is instead due to cholorrhea (a secretory diarrhea that arises from excess bile acids entering the colon) and which requires a very different form of therapy than is required for malabsorption.",
"   </p>",
"   <p>",
"    Management of diarrhea becomes an important aspect of the therapeutic plan in circumstances in which the underlying pathophysiology cannot be entirely corrected. Nonspecific antidiarrheal agents, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     loperamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/56/9094?source=see_link\">",
"     diphenoxylate",
"    </a>",
"    with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    , and deodorized",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/3/35893?source=see_link\">",
"     tincture of opium",
"    </a>",
"    , are useful in this regard. Loperamide should be tried first because it is largely metabolized on first pass through the liver and does not easily cross the blood-brain barrier, minimizing any central nervous system (CNS) side-effects. It is also generally less expensive than diphenoxylate with atropine. Deodorized tincture of opium is useful because of its high potency, which can be particularly useful in severe cases of malabsorption. Because it carries with it a small risk of addiction, patients should be asked about past drug addictions before it is prescribed. In patients with very rapid intestinal transit, the rate of pill dissolution may be a limiting factor: both loperamide and diphenoxylate with atropine also come as liquids, and these forms can be useful in this setting.",
"   </p>",
"   <p>",
"    In many cases dietary maneuvers are helpful adjuncts in the effective management of diarrhea due to malabsorption. Patients should generally avoid more than one serving a day of caffeine-containing beverages since such drinks may promote diarrhea. Highly-sugared beverages such as soft drinks and fruit juices can also markedly increase the volume of diarrhea. This is particularly true in patients with short gut syndrome, where insufficient intestinal absorptive surface remains to compensate for the hyperosmolar effects of such drinks. Diluting soft drinks and fruit juices with water in a 1:1 ratio can be helpful for patients who enjoy such drinks. Patients whose diarrhea causes problems with dehydration and electrolyte disorders should use an oral rehydration solution daily. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32025?source=see_link&amp;anchor=H14#H14\">",
"     \"Approach to the adult with acute diarrhea in developed countries\", section on 'Oral rehydration solutions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients in whom bile acid depletion has an important role in fat malabsorption (eg, chronic cholestasis, major ileal resection), therapy with exogenous conjugated bile acids can decrease steatorrhea. Although such preparations are no longer available by prescription, there are some reliable companies that sell desiccated ox and cattle bile over the internet. However, natural bile acid preparations often increase the volume of diarrhea due to colonic secretion occurring after bacteria in the colon deconjugate the bile acids. This can occur even though they are decreasing the magnitude of steatorrhea. This is generally not of concern in patients who have undergone a colectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/4\">",
"     4",
"    </a>",
"    ]. For patients who have a colon in continuity with the fecal stream, however, a synthetic conjugated bile acid that does not undergo bacterial deconjugation (cholylsarcosine) may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Apart from reducing diarrhea, cholylsarcosine reduces urinary oxalate excretion in patients with short bowel syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/7\">",
"     7",
"    </a>",
"    ]. Cholylsarcosine is presently not available in the United States.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/33/10772?source=see_link\">",
"     Teduglutide",
"    </a>",
"    is a long-acting homolog of the naturally-occurring hormone, GLP-2. It is administered by daily subcutaneous injection. It has trophic effects upon the intestine, anatomically and functionally increasing its absorptive surface area. In a 24-week randomized placebo-controlled trial in patients with short gut syndrome, teduglutide was associated with an improvement in intestinal absorption and nitrogen balance, although it was not associated with a statistically significant reduction in total parenteral fluid requirement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/8\">",
"     8",
"    </a>",
"    ]. Teduglutide may prove to be an important agent in the treatment of short bowel syndrome.",
"   </p>",
"   <p>",
"    Consultation with a dietitian is frequently useful, but in complicated cases assistance from a physician who specializes in nutrition support is preferred since complex nutritional issues are frequently encountered in this setting. It is generally accepted that unintentional weight loss associated with illness that exceeds 10 percent of usual body weight is associated with excess morbidity and mortality due to malnutrition. This degree of weight loss should lead to an aggressive plan for nutritional restitution in the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     NUTRIENT SUPPLEMENTATION AND RESTRICTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with malabsorption have only mild or moderate weight loss. If the disease leading to malabsorption can be specifically treated, most patients can continue with normal dietary intake. Oral supplementation with vitamins and minerals is usually sufficient to correct existing deficiencies, although over the few weeks immediately following the identification of a vitamin or mineral deficiency more rapid recovery can be achieved by supplementation with 5 to 10 times the Daily Value (DV, previously Recommended Dietary Allowance or RDA) (",
"    <a class=\"graphic graphic_table graphicRef51385 \" href=\"UTD.htm?10/6/10349\">",
"     table 2",
"    </a>",
"    ). In patients in whom the malabsorption cannot be corrected, the amount of a particular micronutrient necessary to maintain normal status may continue to be 5 to 10 times the DV.",
"   </p>",
"   <p>",
"    Patients with substantial steatorrhea may require supplementation with more polar forms of fat-soluble vitamins. An example is using the 25-hydroxylated form of vitamin D (calcifediol), which is more polar than vitamin D2 or D3 and is therefore more easily absorbed in patients with fat malabsorption. The serum calcium should be monitored for the first few weeks of therapy with this naturally occurring analogue since it is more potent than vitamin D2 or D3, and can more easily produce hypercalcemia. More recently, 1-hydroxyvitamin D (Hectorol), which is also more polar than vitamin D2 or D3, has become available. In assessing blood levels of vitamin D in patients taking this compound, it is necessary to check 1,25 dihydroxyvitamin D levels rather than the more conventional 25-hydroxyvitamin D, since the 1-hydroxyvitamin D will be converted directly into the dihydroxy form.",
"   </p>",
"   <p>",
"    Similarly, a polar form of vitamin E, d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) has proven to be well absorbed in situations where conventional vitamin E is poorly absorbed due to fat malabsorption.",
"   </p>",
"   <p>",
"    Some fat-soluble vitamins can also be obtained in capsules containing an emulsifying solution (eg, Aquasol A&reg;, Aquasol E&reg;). However, it remains unproven if these preparations actually enhance absorption of the vitamins.",
"   </p>",
"   <p>",
"    A variety of other nutrients are often required in specific situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Iron and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      supplementation are usually required in celiac disease; in some cases, deficiencies of these nutrients are the presenting manifestation of the disease [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Calcium and magnesium supplementation are required after extensive small intestinal resection, or in any setting where there is severe fat malabsorption. Both vitamin D malabsorption as well as excessive fecal loss of calcium and magnesium (because of binding to malabsorbed fatty acids in the intestinal lumen) contribute to these deficiencies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18007?source=see_link\">",
"       \"Chronic complications of the short bowel syndrome in adults\"",
"      </a>",
"      .) Vitamin D deficiency worsens calcium deficiency. Optimal maintenance of bone mass is best achieved when serum 25-hydroxyvitamin D levels are maintained in the upper end of the normative range, or slightly above (ie, 30 to 50",
"      <span class=\"nowrap\">",
"       ng/mL)",
"      </span>",
"      among those using vitamins D2, D3 or 25-hydroxy vitamin D as a supplement. Among those taking the 1-hydroxylated form of the vitamin, the optimal blood concentrations of vitamin D metabolites are less clear. It would probably best in the latter situation to aim for a blood level within the normative range for 1,25 dihydroxy vitamin D. In patients who have fat malabsorption and a colon in continuity with the fecal stream, calcium supplementation also assists in the prevention of nephrolithiasis due to oxalate stones.",
"     </li>",
"     <li>",
"      Magnesium is also unique among the minerals since it is primarily absorbed in the distal small intestine and colon. In patients who have lost substantial amounts of distal small gut and colon, magnesium depletion may arise even in the absence of fat malabsorption. Magnesium salts, when taken orally, often induce an osmotic diarrhea so parenteral repletion may be necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to recall that serum concentrations of calcium and magnesium may be poor indicators of homeostasis of these cations. The possibility of normomagnesemic magnesium depletion (in which there is isolated intracellular magnesium depletion) should be considered as a possible cause of refractory hypokalemia or unexplained hypocalcemia in patients at high risk for magnesium loss since magnesium is necessary for both parathyroid hormone (PTH) release and for its actions in the target tissues. Measuring the response to an oral magnesium load has been suggested as a clinically meaningful method to detect normomagnesemic magnesium depletion. The utility is uncertain; it may be simpler to administer magnesium if there are reasons to suspect magnesium depletion. As an example, magnesium depletion should be suspected in any patient with the otherwise unexplained combination of hypocalcemia and hypokalemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/63/11254?source=see_link&amp;anchor=H3#H3\">",
"     \"Evaluation and treatment of hypomagnesemia\", section on 'Normomagnesemic magnesium depletion'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link\">",
"     \"Signs and symptoms of magnesium depletion\"",
"    </a>",
"    .) Magnesium salts are poorly absorbed and may exacerbate underlying diarrhea so intermittent parenteral administration is sometimes necessary.",
"   </p>",
"   <p>",
"    In the setting of persistent malabsorption, occasional monitoring of bone mass with dual photon absorptiometry (\"DEXA\") is indicated since the incidence of metabolic bone disease is quite high in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/28/40393?source=see_link\">",
"     \"Screening for osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Additional dietary principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary restrictions in some diseases leading to malabsorption can result in full restoration of mucosal function and nutritional status. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A gluten-free diet in patients with celiac disease.",
"     </li>",
"     <li>",
"      Elimination of a particular carbohydrate in patients with isolated carbohydrate deficiencies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/50/41765?source=see_link\">",
"       \"Mechanisms of nutrient absorption and malabsorption\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A reduction in dietary long chain fatty acids below 40",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      in patients with steatorrhea can reduce stool volume and stool fat content to acceptable levels. However, this may unduly restrict the patient's ability to consume sufficient calories, in which case supplementation with medium-chain triglyceride (MCT) oil or MCT-based liquid supplements is indicated [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/11\">",
"       11",
"      </a>",
"      ]. The use of pure MCT as a cooking oil, spread on toast, or salad dressing can be a double-edged sword since it occasionally induces nausea or an osmotic diarrhea. MCT-based liquid nutritional supplements are no longer readily available on the United States. However, a substitute can be made by adding 10 mL of MCT oil to 8 ounces of nonfat milk, to which is added one packet of a powdered instant breakfast meal and briefly emulsified in a blender. Nonfat",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"       lactase",
"      </a>",
"      -treated milk should be used in patients who are lactose intolerant. Among those with short bowel syndrome, carefully performed energy balance studies suggest that MCT is most effective in patients whose colons remain in the fecal stream, since a major site of MCT absorption appears to be the colon [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A low fat diet is an important component of the treatment regimen for patients with fat malabsorption due to short bowel syndrome if the colon is in continuity. Some authorities suggest that a high fat diet can also be used with an intact colon to increase energy absorption. Such an approach can be considered in individual patients but the tradeoff will probably be increased diarrhea and divalent cation loss.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fat restriction does not present an advantage with respect to net fluid, energy, nitrogen, or electrolyte absorption if a jejunostomy or ileostomy is present [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/13\">",
"     13",
"    </a>",
"    ]. In the latter situations, a patient may more easily achieve caloric goals, and thereby a stable weight, if no fat restriction is imposed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Lactose intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elimination of milk and milk products from the diet leads to improvement in primary",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    deficiency. In acquired forms of lactose intolerance due to small intestinal disease, treatment of the underlying disease or its complications may improve lactose tolerance without requiring dietary modification. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/32/5641?source=see_link\">",
"     \"Lactose intolerance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence and underlying cause of lactose intolerance in patients with small intestinal disease should be established prior to suggesting a lactose-free diet. As an example, the prevalence of lactose malabsorption is significantly higher in patients with Crohn's disease with extensive small bowel involvement than in those with colonic disease alone. However, lactose malabsorption in Crohn's disease of the small bowel may result from factors other than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    enzyme activity, such as bacterial overgrowth",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diminished small bowel transit time, each of which can improve during treatment.",
"   </p>",
"   <p>",
"    Recommending a lactose-free diet in such patients imposes an added inconvenience and deprives them of a valuable source of nutrition (especially calcium and vitamin D). When symptoms of lactose intolerance arise during a flare of the disease, restricting dietary lactose temporarily may be sufficient. Commercially available lactose-free milk products can help to minimize symptoms, allowing for more generous ingestion of dairy foods.",
"   </p>",
"   <p>",
"    Finally, intolerance to dairy products is not necessarily due to lactose intolerance. Allergy to milk proteins, as well as psychologic factors, may also have a role. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/32/5641?source=see_link\">",
"     \"Lactose intolerance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fructose intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to one-half of the population cannot completely absorb a load of 25 g of fructose while daily intake varies from about 11 to 54 g per day [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/14-20\">",
"     14-20",
"    </a>",
"    ]. In a study of healthy volunteers, 10 percent had positive breath test results after consuming 25 g of fructose while 80 percent had positive results with a 50 g load [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concern over fructose malabsorption has grown with the increasingly widespread use of high fructose corn syrups that are used to sweeten a wide variety of commercial food products. However, the degree to which fructose malabsorption contributes to gastrointestinal symptoms is not clearly established. Gastrointestinal symptoms related to fructose malabsorption appear to be more common in individuals who have an underlying functional bowel disorder such as irritable bowel syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/15,17,21\">",
"     15,17,21",
"    </a>",
"    ]. Unabsorbed fructose provides a substrate for rapid bacterial fermentation (causing gas), and may have other physiological consequences including an increased osmotic load and alteration of gastrointestinal motility (which may cause diarrhea), and a change in the profile of the bacterial flora.",
"   </p>",
"   <p>",
"    Dietary fructose is consumed in two forms: as a monosaccharide, and as a disaccharide, since it is contained in sucrose (glucose-fructose). For reasons that are incompletely understood, fructose absorption from sucrose is greater than the absorption of fructose as a monosaccharide [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/16,19\">",
"     16,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ability to absorb fructose (even in those with malabsorption) depends not only upon the amount of fructose consumed, but the presence of other sugars ingested with it. Concomitant ingestion of glucose, galactose, and some amino acids increases fructose absorption, while",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    decreases it [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/19,22\">",
"     19,22",
"    </a>",
"    ]. These observations have implications for dietary recommendations in patients in whom fructose malabsorption is suspected since foods that contain fructose may be well tolerated if they also contain glucose but may be less well tolerated if they also contain sorbitol (although sorbitol itself can cause diarrhea). Thus, it is the net amount of fructose that is important.",
"   </p>",
"   <p>",
"    There are two commercially used forms of high fructose corn syrup (HFCS), one that contains approximately 42 percent and the other approximately 55 percent fructose (HFCS-55). The other main ingredient is glucose. For example, a 12-ounce soda containing HFCS-55 has about 22 g of fructose and 17 g of glucose providing an excess of only 5 g of fructose per can, an amount that can be absorbed completely in most healthy individuals. Thus, despite an abundance of fructose, HFCS may not be a major culprit in causing symptoms in individuals with fructose malabsorption (provided that its ingestion is modest) since it also contains similar amounts of glucose.",
"   </p>",
"   <p>",
"    Patients in whom a trial of dietary avoidance of fructose is desired should be advised to avoid foods that contain a high net amount of fructose (ie, more fructose than glucose, or more fructose and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    than glucose). In particular, they should reduce or temporarily eliminate their intake of [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Foods sweetened with \"fructose\" or \"crystalline fructose\".",
"     </li>",
"     <li>",
"      Juices and fruits containing high net amounts of fructose (eg, apples, pears, sweet cherries, prunes, dates), and beverages sweetened with high fructose corn syrup. If consumed, these foods should be eaten with meals, and beverages sweetened with high fructose corn syrup limited to 12 ounces. Because long-term elimination of these healthful fruits is not generally advisable, it should only be entertained if objective evidence of fructose malabsorption is obtained (see below) or if unequivocal benefits are obtained with their elimination.",
"     </li>",
"     <li>",
"      Honey, which contains 35 g of fructose and 29 g of glucose per 100 g (3 tablespoons).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       Sorbitol",
"      </a>",
"      -containing candies and gums, which, as noted above, may decrease fructose absorption but may cause diarrhea because of the osmotic effects and breakdown products of sorbitol and sugar alcohol. Many foods are labeled \"sugarless,\" which is a misnomer because the products contain poorly absorbed sugar moieties.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A fructose breath test has been suggested as an objective means of identifying fructose intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/23\">",
"     23",
"    </a>",
"    ]. Further validation of the predictive value of this test is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pancreatic insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstay of treatment in severe maldigestion and steatorrhea due to exocrine pancreatic insufficiency is a low fat diet and administration of exogenous pancreatic enzymes. To optimize the efficacy of treatment, the management of exocrine pancreatic insufficiency must be individually tailored to account for both the underlying cause and any associated disturbance in gastrointestinal physiology. In addition, the properties of the pancreatic enzyme preparations and adjuvant drugs need to be taken into consideration.",
"   </p>",
"   <p>",
"    Several commercial preparations are microencapsulated (",
"    <a class=\"graphic graphic_table graphicRef51385 \" href=\"UTD.htm?10/6/10349\">",
"     table 2",
"    </a>",
"    ), and are thereby designed to be acid-resistant to avoid enzyme inactivation by gastric juice. As a general rule, 30,000 IU of pancreatic lipase, swallowed during each full meal, should suffice in reducing steatorrhea and preventing weight loss. One-half of that dose should be administered with snacks. Determining the adequate amount of lipase can be confusing since the amount of lipase in pancreatic supplements is typically expressed in USP units. One IU is equivalent to approximately 2 to 3 USP units. If symptoms persist, supplemental therapy with H2 receptor antagonists or proton pump inhibitors is often effective [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22279/abstract/24\">",
"     24",
"    </a>",
"    ]. Nonencapsulated formulations may be more successful in patients who are achlorhydric or who have dyssynchronous gastric emptying (eg, Billroth II anatomy), since there is no need to protect the enzymes from acid. Microencapsulated formulations will only delay the release of the enzymes in the proximal small intestine, and are therefore intended more for patients who have retained the ability to secrete gastric acid. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31369?source=see_link\">",
"     \"Treatment of chronic pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/31/22002?source=see_link\">",
"       \"Patient information: Gas and bloating (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/26/11684?source=see_link\">",
"       \"Patient information: Lactose intolerance (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/14/6371?source=see_link\">",
"       \"Patient information: Gas and bloating (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of patients with malabsorption and maldigestion consists of treatment of the underlying disease, management of accompanying diarrhea, and correction of nutritional deficits. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Principles of management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because many diseases may lead to malabsorption, there is no nonspecific or generally recommended treatment. As a result, the exact diagnosis is essential for successful therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=see_link\">",
"       \"Clinical features and diagnosis of malabsorption\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Most patients presenting with malabsorption have only mild or moderate weight loss. If the underlying disease leading to malabsorption can be specifically treated, most patients can continue with normal dietary intake. Dietary principles for patients with more severe, intractable, or specific forms of malabsorption are summarized above. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Nutrient supplementation and restriction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary restrictions in some diseases leading to malabsorption can result in full restoration of mucosal function and nutritional status. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Additional dietary principles'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Greenberger NJ. Celiac sprue and other malabsorptive disorders. In: Therapy of Digestive Disorders, Wolfe MM (Ed), Saunders, Philadelphia 2006. p.711.",
"    </li>",
"    <li>",
"     Farrell JJ. Digestion and absorption of nutrients and vitamins. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed, Feldman M, Friedman L, Brandt L (Eds), Saunders Elsevier, Philadelphia 2006. p.2147.",
"    </li>",
"    <li>",
"     Hogenauer C, Hammer HF. Maldigestion and malabsorption. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed, Feldman M, Friedman L, Brandt L (Eds), Saunders Elsevier, Philadelphia 2006. p.2199.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/4\">",
"      Gruy-Kapral C, Little KH, Fordtran JS, et al. Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology 1999; 116:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/5\">",
"      Kapral C, Wewalka F, Praxmarer V, et al. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon. Z Gastroenterol 2004; 42:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/6\">",
"      Heydorn S, Jeppesen PB, Mortensen PB. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 1999; 34:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/7\">",
"      Emmett M, Guirl MJ, Santa Ana CA, et al. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome. Am J Kidney Dis 2003; 41:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/8\">",
"      Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011; 60:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/9\">",
"      Johnston SD, Watson RG, McMillan SA, et al. Preliminary results from follow-up of a large-scale population survey of antibodies to gliadin, reticulin and endomysium. Acta Paediatr Suppl 1996; 412:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/10\">",
"      Williams SE, Seidner DL. Metabolic bone disease in gastrointestinal illness. Gastroenterol Clin North Am 2007; 36:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/11\">",
"      Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr 1997; 65:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/12\">",
"      Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998; 43:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/13\">",
"      Woolf GM, Miller C, Kurian R, Jeejeebhoy KN. Diet for patients with a short bowel: high fat or high carbohydrate? Gastroenterology 1983; 84:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/14\">",
"      Gibson PR, Newnham E, Barrett JS, et al. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007; 25:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/15\">",
"      Choi YK, Johlin FC Jr, Summers RW, et al. Fructose intolerance: an under-recognized problem. Am J Gastroenterol 2003; 98:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/16\">",
"      Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology 1983; 84:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/17\">",
"      Rumessen JJ, Gudmand-H&oslash;yer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988; 95:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/18\">",
"      Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990; 99:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/19\">",
"      Skoog SM, Bharucha AE. Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol 2004; 99:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/20\">",
"      Rao SS, Attaluri A, Anderson L, Stumbo P. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol 2007; 5:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/21\">",
"      Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/22\">",
"      Rumessen JJ, Gudmand-H&oslash;yer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/23\">",
"      Johlin FC Jr, Panther M, Kraft N. Dietary fructose intolerance: diet modification can impact self-rated health and symptom control. Nutr Clin Care 2004; 7:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22279/abstract/24\">",
"      Bruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol 1995; 90:1383.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4782 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22279=[""].join("\n");
var outline_f21_48_22279=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NUTRIENT PROCESSING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PRINCIPLES OF MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NUTRIENT SUPPLEMENTATION AND RESTRICTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Additional dietary principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Lactose intolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fructose intolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pancreatic insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4782\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4782|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/6/5229\" title=\"table 1\">",
"      Mechanisms of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/6/10349\" title=\"table 2\">",
"      Medications for malabsorption",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18007?source=related_link\">",
"      Chronic complications of the short bowel syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=related_link\">",
"      Clinical features and diagnosis of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/63/11254?source=related_link\">",
"      Evaluation and treatment of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/32/5641?source=related_link\">",
"      Lactose intolerance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/50/41765?source=related_link\">",
"      Mechanisms of nutrient absorption and malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/14/6371?source=related_link\">",
"      Patient information: Gas and bloating (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/31/22002?source=related_link\">",
"      Patient information: Gas and bloating (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/26/11684?source=related_link\">",
"      Patient information: Lactose intolerance (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/28/40393?source=related_link\">",
"      Screening for osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31369?source=related_link\">",
"      Treatment of chronic pancreatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_48_22280="Trichuriasis eggs";
var content_f21_48_22280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Trichuriasis eggs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 545px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Egg of",
"    <em>",
"     T. trichiura",
"    </em>",
"    in an iodine-stained wet mount.",
"    <br/>",
"    (B) Egg of",
"    <em>",
"     T. trichiura",
"    </em>",
"    in an unstained wet mount.",
"    <br/>",
"    (C) Egg of",
"    <em>",
"     T. trichiura",
"    </em>",
"    in an unstained wet mount.",
"    <br/>",
"    (D) Two eggs of",
"    <em>",
"     T. trichiura",
"    </em>",
"    , showing the variability in size of the species.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Trichuriasis. Available at:",
"     <a href=\"file://dpd.cdc.gov/dpdx/html/Trichuriasis.htm\" target=\"_blank\">",
"      file://dpd.cdc.gov/dpdx/html/Trichuriasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22280=[""].join("\n");
var outline_f21_48_22280=null;
var title_f21_48_22281="The common cold in children: Clinical features and diagnosis";
var content_f21_48_22281=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The common cold in children: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22281/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22281/contributors\">",
"     Diane E Pappas, MD, JD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22281/contributors\">",
"     J Owen Hendley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22281/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22281/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22281/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22281/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/48/22281/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common cold is an acute, self-limiting viral infection of the upper respiratory tract, involving, to variable degrees, sneezing, nasal congestion and discharge (rhinorrhea), sore throat, cough, low grade fever, headache, and malaise. It can be caused by members of several families of viruses; the most common are the more than 100 serotypes of rhinoviruses.",
"   </p>",
"   <p>",
"    The common cold is the most frequent human illness. An estimated 25 million individuals seek medical care for uncomplicated upper respiratory tract infections (URI) annually in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Approximately 30 percent of these visits result in a prescription for antibiotics. Inaccurate perceptions that colds are caused by bacteria and that antibiotics improve outcome fuel the number of visits and requests for antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/3\">",
"     3",
"    </a>",
"    ]. Infants and children are affected more often and experience more prolonged symptoms than adults. The common cold accounts for approximately 22 million missed days of school and 20 million absences from work, including parents&rsquo; time away from work while caring for ill children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, clinical features, complications, and diagnosis of the common cold in children will be discussed here. The treatment and prevention of the common cold in children and the common cold in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13146?source=see_link\">",
"     \"The common cold in children: Treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=see_link\">",
"     \"The common cold in adults: Diagnosis and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link\">",
"     \"The common cold in adults: Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066514\">",
"    <span class=\"h1\">",
"     VIROLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of the common cold can be caused by a variety of viruses. Rhinoviruses, which include more than 100 serotypes, cause up to 50 percent of colds in children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2\">",
"     2",
"    </a>",
"    ]. Other common causes of colds in preschool children include respiratory syncytial virus (RSV), influenza viruses, parainfluenza viruses, and adenoviruses (",
"    <a class=\"graphic graphic_table graphicRef56841 \" href=\"UTD.htm?29/59/30652\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"     \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H15#H15\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cold symptoms also can be caused by nonpolio enteroviruses (echoviruses and coxsackieviruses), coronaviruses, and human metapneumovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=see_link\">",
"     \"Coronaviruses\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=see_link\">",
"     \"Human metapneumovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many of the viruses that cause colds also cause other characteristic clinical syndromes in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RSV &ndash; Bronchiolitis in children younger than the age of two years (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H7#H7\">",
"       \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H15#H15\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Influenza viruses &ndash; Influenza, pneumonia, and croup (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Parainfluenza viruses &ndash; Croup (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43529?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features, evaluation, and diagnosis of croup\", section on 'Clinical presentation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"       \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Coxsackievirus A (an enterovirus) &ndash; Herpangina (fever and ulcerated papules on the posterior oropharynx) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link&amp;anchor=H6#H6\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Herpangina'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Other nonpolio enteroviruses &ndash; Aseptic meningitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=see_link&amp;anchor=H3#H3\">",
"       \"Viral meningitis: Clinical features and diagnosis in children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Adenoviruses &ndash; Pharyngoconjunctival fever (palpebral conjunctivitis, watery eye discharge, and pharyngeal erythema) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link\">",
"       \"Epidemiology and clinical manifestations of adenovirus infection\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Human metapneumovirus &ndash; Pneumonia and bronchiolitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/5,6\">",
"       5,6",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=see_link&amp;anchor=H9#H9\">",
"       \"Human metapneumovirus infections\", section on 'Children'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199069241\">",
"    <span class=\"h2\">",
"     Immune response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhinoviruses, adenoviruses, influenza viruses, and enteroviruses produce lasting immunity, but immunity does little to prevent subsequent colds because there are so many serotypes. RSV, parainfluenza viruses, and coronaviruses do not produce lasting immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Reinfection may occur, but subsequent infection with the same agent is generally milder and of shorter duration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066715\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Seasonal patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common cold may occur at any time of year, but there is typically a high prevalence during the fall and winter months as the different viruses move through the community in a predictable manner. In the northern hemisphere, this yearly epidemic begins with an increase in the number of rhinovirus infections in September [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/9\">",
"     9",
"    </a>",
"    ], followed by parainfluenza viruses in October and November. The winter months are characterized by an increase in respiratory syncytial virus (RSV), influenza viruses, and coronaviruses [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/10\">",
"     10",
"    </a>",
"    ]. Adenovirus infections are continuously present at a low rate throughout the cold season. The epidemic finally ends with a small wave of rhinovirus infections in March and April [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/11\">",
"     11",
"    </a>",
"    ]. Enteroviruses most often cause illness in the summer, but can be detected throughout the year.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses that cause colds are spread by three mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hand contact: Self-inoculation of one&rsquo;s own conjunctivae or nasal mucosa after touching a person or object contaminated with cold virus",
"     </li>",
"     <li>",
"      Inhalation of small particle droplets that become airborne from coughing (droplet transmission)",
"     </li>",
"     <li>",
"      Deposition of large particle droplets that are expelled during sneezing and land on nasal or conjunctival mucosa (typically requires close contact with an infected person)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most successful means of viral spread for the majority of upper respiratory infections (URI), including rhinoviruses, is transmission of infectious secretions from contaminated fingers and hands to the mucous membranes of the nose or eyes of a susceptible recipient [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/12\">",
"     12",
"    </a>",
"    ]. The risk of person-to-person transfer is dependent upon the amount of time people spend together, the proximity of their contact with one another, and the amount of virus shed by the infected patient. In experimental studies, rhinovirus was efficiently transferred from hand-to-hand after minimal contact (10 seconds) and subsequent contact with nasal or conjunctival mucosa resulted in infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/13\">",
"     13",
"    </a>",
"    ]. Particle aerosols were an inefficient method of rhinovirus transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. However, both influenza virus and coronavirus can be transmitted via aerosols. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Transmission'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=see_link&amp;anchor=H5#H5\">",
"     \"Coronaviruses\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Substantial titers of rhinovirus are present in nasal secretions of infected individuals. Low titers of rhinovirus are present in saliva in approximately one-half of infected individuals. Viral contamination of the hands of infected individuals is common. Rhinoviruses may remain viable on human skin for as long as two hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/15\">",
"     15",
"    </a>",
"    ]. Rhinoviruses also can survive for up to one day on inanimate surfaces although porous materials such as tissues and cotton handkerchiefs do not appear to support virus survival [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/15-18\">",
"     15-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surface contamination of pediatric office toys with respiratory viral RNA does not appear to be an important method of transfer. In an observational study, approximately 20 percent of the toys in a pediatric office waiting room were contaminated with picornavirus RNA (rhinovirus or enterovirus). Cleaning with a disposable germicidal wipe (containing quaternary ammonium with alcohol) was only modestly effective in removing the viral RNA, but transfer from the toys to the fingers was inefficient [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066530\">",
"    <span class=\"h2\">",
"     Period of infectivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral shedding peaks on the third day after inoculation; this coincides with a peak in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. In experimental studies, viral titers in nasal washings returned to near baseline values by five days after inoculation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/20\">",
"     20",
"    </a>",
"    ]. Low levels of viral shedding may persist for up to two weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199067084\">",
"    <span class=\"h2\">",
"     Incubation period",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period (time between contact with infectious material until the onset of symptoms) for most common cold viruses is 24 to 72 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of the common cold are largely due to the innate immune response to infection, rather than to direct viral damage to the respiratory tract [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/22\">",
"     22",
"    </a>",
"    ]. After deposition on nasal or conjunctival mucosa, cold viruses attach to receptors on epithelial cells in the nasopharynx and enter the cells [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"     7",
"    </a>",
"    ]. During rhinovirus infection, viral replication occurs in only a small number of nasal epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The infected cells release cytokines, including interleukin (IL)-8, which attracts polymorphonuclear cells (PMNs) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. Large numbers of PMNs (100-fold increase) accumulate in the nasal secretions and mucociliary clearance is slowed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms usually appear one to two days after viral inoculation, coinciding with the influx of PMNs in the nasal submucosa and epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. The severity of symptoms correlates with mucosal IL-8 concentrations. A change in the character of the nasal discharge from clear to",
"    <span class=\"nowrap\">",
"     yellow/white",
"    </span>",
"    or green correlates with the increase in PMNs, but not with an increase in positive bacterial cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/31\">",
"     31",
"    </a>",
"    ]. The colored discharge may signify the presence of PMNs (yellow or white) or of PMN enzymatic activity (green color).",
"   </p>",
"   <p>",
"    By an unknown mechanism, rhinovirus infection increases vascular permeability in the nasal submucosa, releasing albumin and kinins (bradykinin), which may then contribute to the symptoms of the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/28,32\">",
"     28,32",
"    </a>",
"    ]. Bradykinin causes rhinitis and sore throat when sprayed into the noses of volunteers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/33\">",
"     33",
"    </a>",
"    ]. Histamine concentration does not increase in experimental rhinovirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/28,32\">",
"     28,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Histologic studies in young adults with natural and experimentally induced colds demonstrate that the nasal epithelium remains intact, although there is an influx of PMNs into the nasal submucosa and epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In vitro, rhinoviruses and coronaviruses do not cause gross destruction of nasal epithelial cells; however, adenoviruses and influenza A have a cytopathic effect, with resultant destruction of nasal epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H647321191\">",
"    <span class=\"h2\">",
"     Frequency and duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children younger than six years have an average of six to eight colds per year (up to one per month, September through April), with a typical symptom duration of 14 days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,35\">",
"     2,35",
"    </a>",
"    ]. Young children in daycare appear to have more colds than children cared for at home. However, when they enter primary school, children who attended daycare are less vulnerable to colds than those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Older children and adults have an average of two to four colds per year, with a typical symptom duration of five to seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]. The duration of symptoms is increased among cigarette smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H714086587\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H565532947\">",
"    <span class=\"h3\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptom profile of the common cold varies from patient to patient, in part due to age, and in part due to the causative virus, although the wide range and overlapping manifestations of the various cold-causing viruses make it impossible to determine the specific causative virus without laboratory testing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,8,35\">",
"     2,8,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In infants, fever and nasal discharge are common manifestations. Additional manifestations may include fussiness, difficulty feeding, decreased appetite, and difficulty sleeping.",
"   </p>",
"   <p>",
"    In school-aged children, nasal congestion, nasal discharge and cough are the predominant symptoms. In a prospective study of 81 colds in school-aged children (5 to 12 years), parents recorded signs and symptoms during the first 10 days of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/35\">",
"     35",
"    </a>",
"    ]. Signs and symptoms included cough, sneeze, feverish (defined as ill-appearing, flushed, warm to touch), congestion, nasal discharge, and headache; sore throat and hoarseness were not evaluated. Rhinovirus RNA was detected in 46 percent of episodes. The frequency and duration of the various manifestations were as follows (",
"    <a class=\"graphic graphic_figure graphicRef65898 \" href=\"UTD.htm?4/28/4559\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nasal congestion was reported in 59 percent at the onset of illness, peaked (88 percent) on day 3, and persisted in &ge;75 percent on day 7",
"     </li>",
"     <li>",
"      Runny nose peaked (72 percent) on day 3 and persisted in &ge;50 percent on day 6",
"     </li>",
"     <li>",
"      Cough was reported in 46 percent at onset, peaked (69 percent) on day 1, and persisted in &ge;50 percent on day 8",
"     </li>",
"     <li>",
"      Sneezing was reported in 36 percent at the onset of illness, peaked (55 percent) on day 1, and persisted in &ge;35 percent on day 6",
"     </li>",
"     <li>",
"      Feverishness was reported in 15 percent at the onset of illness and declined over the first three days",
"     </li>",
"     <li>",
"      Headache was reported in 15 percent at the onset of illness, 20 percent on day 1, and approximately 15 percent through day 4",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately three-quarters of children remained symptomatic on day 10 of illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H565532988\">",
"    <span class=\"h3\">",
"     Fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever may be the predominant manifestation of the common cold during the early phase of infection in young children. It is uncommon in older children and adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=see_link&amp;anchor=H7#H7\">",
"     \"The common cold in adults: Diagnosis and clinical features\", section on 'Clinical features'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    New onset of fever or recurrence of fever (if one was present at the onset of illness) may indicate secondary bacterial infection (eg, acute otitis media, sinusitis, pneumonia). (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H565532995\">",
"    <span class=\"h3\">",
"     Nasal manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal congestion, nasal discharge, and sneezing are common in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/35\">",
"     35",
"    </a>",
"    ]. Examination may reveal erythema and swelling of the nasal mucosa and nasal discharge. Nasal discharge may be clear initially, but often becomes colored (yellow or green) within a few days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"     7",
"    </a>",
"    ]. Coloring of the nasal discharge is probably related to the increase in number or enzymatic activity of polymorphonuclear cells [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/31\">",
"     31",
"    </a>",
"    ]. Coloring of the nasal discharge does not indicate bacterial superinfection or acute bacterial sinusitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,31\">",
"     2,31",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"    <br/>",
"    <br/>",
"    Acute bacterial sinusitis may be indicated by persistence of nasal discharge for more than 10 days",
"    <strong>",
"     without improvement",
"    </strong>",
"    , severe symptoms, or worsening symptoms (as defined below). (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Sinusitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H565533016\">",
"    <span class=\"h3\">",
"     Cough",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cough occurs in more than two-thirds of children with the common cold and may be the most bothersome symptom for the child&rsquo;s caregivers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/35,39\">",
"     35,39",
"    </a>",
"    ]. Cough may affect the child&rsquo;s sleep, school performance, and ability to play; it also may disturb the sleep of other family members and be disruptive in the classroom [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/40\">",
"     40",
"    </a>",
"    ]. The cough may linger for an additional week or two after other symptoms have resolved, but should gradually improve. Diagnoses other than the common cold should be considered if the cough worsens or fails to improve. (See",
"    <a class=\"local\" href=\"#H199066646\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H565533002\">",
"    <span class=\"h3\">",
"     Other symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other symptoms and signs of the common cold may include sore throat (typically an early manifestation), hoarseness, headache, irritability, difficulty sleeping, decreased appetite, anterior cervical adenopathy, and conjunctival injection. Vomiting and diarrhea are uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,7,35\">",
"     2,7,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H374394953\">",
"    <span class=\"h2\">",
"     Middle ear abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Middle ear abnormalities are common during the course of an uncomplicated cold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In an observational study of 86 children (2 to 12 years) with colds, two-thirds had abnormal middle ear pressure (assessed by tympanometry) at some point during the two weeks after onset [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/41\">",
"     41",
"    </a>",
"    ]. Abnormal middle ear pressures were most common during the first week. They shifted from ear to ear and were present only intermittently during the course of the cold.",
"   </p>",
"   <p>",
"    Abnormal middle ear pressure may predispose to the development of acute otitis media. The development of acute otitis media is not affected by treatment with combination decongestant-antihistamines [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H199066547\">",
"     'Acute otitis media'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The cause of abnormal middle ear pressure during the common cold is unknown. Viral nasopharyngitis may result in Eustachian tube dysfunction and abnormal middle ear pressure, or abnormal middle ear pressure may result from the viral infection of the mucosa of the middle ear",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Eustachian tube.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H374394904\">",
"    <span class=\"h2\">",
"     Radiographic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-limiting radiographic abnormalities of the paranasal sinuses are common during the course of an uncomplicated cold:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 31 healthy young adults with the recent onset of cold symptoms, abnormalities of the paranasal sinuses were evident on computed tomographic (CT) scans during the acute phase of illness in 27 (87 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/44\">",
"       44",
"      </a>",
"      ]. Antibiotics were not administered, and follow-up CT scans two weeks later showed complete resolution or marked improvement in 11 of the 14 subjects evaluated (79 percent).",
"     </li>",
"     <li>",
"      In another study, 37 (62 percent) of 60 children (4 to 7 years old) with a cold had major abnormalities (more than one-third volume loss or air-fluid level) in their maxillary",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ethmoid sinuses by magnetic resonance imaging (MRI). Twenty-six of the 37 had a follow-up MRI at two weeks; 30 percent had a new cold and two had received an antibiotic. At follow-up, the major abnormalities were no longer present in 54 percent of ethmoid and 65 percent of maxillary sinuses [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unknown whether these abnormalities are the result of impaired sinus drainage or the result of actual viral infection of the sinus mucosa. Nose blowing has been demonstrated to propel nasal secretions into the paranasal sinuses [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/46\">",
"     46",
"    </a>",
"    ]. However, the degree to which this contributes to the accumulation of fluid in the sinuses is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066547\">",
"    <span class=\"h2\">",
"     Acute otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of children with a cold have abnormal middle ear pressure at some point during its course. (See",
"    <a class=\"local\" href=\"#H374394953\">",
"     'Middle ear abnormalities'",
"    </a>",
"    above.) Abnormal middle ear pressure may predispose to acute otitis media (AOM).",
"   </p>",
"   <p>",
"    The risk of secondary acute otitis media is greatest among children 6 to 11 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"     7",
"    </a>",
"    ]. Approximately one-third to one-half of colds in young children are complicated by development of AOM as defined by acute onset of symptoms, inflammation of the tympanic membrane, and fluid in the middle ear [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. However, bacterial or suppurative otitis media, defined as a bulging tympanic membrane with purulent material behind it or purulent otorrhea from perforation of the tympanic membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/50\">",
"     50",
"    </a>",
"    ], occurs in only 5 to 19 percent of colds in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/49\">",
"     49",
"    </a>",
"    ]. In a prospective study, the frequency of AOM was increased among children who had middle ear effusion before they developed the cold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AOM may be indicated by new-onset fever and earache after the first few days of cold symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=see_link&amp;anchor=H19#H19\">",
"     \"Acute otitis media in children: Diagnosis\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Asthma exacerbation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral upper respiratory infections (URI) commonly are associated with wheezing in susceptible children and are associated with at least 50 percent of asthma exacerbations in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26010?source=see_link&amp;anchor=H9#H9\">",
"     \"Chronic asthma in children younger than 12 years: Evaluation and diagnosis\", section on 'Viral URI'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Sinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral URI is the most important risk factor for the development of bacterial sinusitis. Between 6 and 13 percent of viral URIs in children are complicated by acute bacterial sinusitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H6#H6\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Predisposing factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Secondary bacterial infection of the paranasal sinuses may be indicated by (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H7#H7\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Clinical features'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent nasal symptoms",
"      <strong>",
"       without improvement",
"      </strong>",
"      for more than 10 days, or",
"     </li>",
"     <li>",
"      Severe symptoms (temperature &ge;39&deg;C [102.2&deg;F], ill-appearance, purulent nasal discharge for three to four days), or",
"     </li>",
"     <li>",
"      Worsening symptoms (exacerbation of nasal discharge or cough, new onset fever, or recurrence of fever)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Lower respiratory tract disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial pneumonia is an uncommon complication of the common cold. It may be indicated by new-onset fever after the first few days of cold symptoms. Prolonged cough in the absence of a new fever may signify viral lower respiratory tract infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other complications of the common cold in children may include epistaxis, conjunctivitis, and pharyngitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology and etiology of epistaxis in children\", section on 'Mucosal irritation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20760?source=see_link&amp;anchor=H6#H6\">",
"     \"Conjunctivitis\", section on 'Viral conjunctivitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H8#H8\">",
"     \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Viruses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066638\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of the common cold is made clinically, based upon history and examination findings, including exposure to someone with a cold, nasal congestion, nasal discharge, sore throat, fever (in young children), anterior cervical adenopathy, and erythema of nasal mucosa and oropharynx [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"     7",
"    </a>",
"    ]. Laboratory tests are not helpful in making the diagnosis. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Clinical features that may indicate a diagnosis other than an uncomplicated cold include persistent fever, high-fever (&gt;39&deg;C [102.2&deg;F]), ill-appearance, absence of nasal symptoms, oral mucosal lesions (eg, the posterior vesicles of herpangina), wheezing, focal findings on lung examination (eg, dullness to percussion, reduced air entry, crackles, bronchial breathing), hemoptysis, acute",
"    <span class=\"nowrap\">",
"     onset/choking",
"    </span>",
"    (may suggest inhaled foreign body),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    features of a chronic respiratory disorder (eg, failure to thrive, finger clubbing, over-inflated chest, chest deformity, atopy) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/40,51,52\">",
"     40,51,52",
"    </a>",
"    ]. Chest radiography may be warranted in children with focal findings on lung examination, relentlessly progressive cough, hemoptysis, or features of an undiagnosed chronic respiratory disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Complications'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H199066646\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Laboratory testing can identify the viral pathogen if it is necessary to do so [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2\">",
"     2",
"    </a>",
"    ]. The wide range and overlapping manifestations of the various cold-causing viruses make it impossible to clinically determine the causative virus in an individual patient [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066646\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of the common cold includes other causes of rhinitis (allergic, seasonal, vasomotor, rhinitis medicamentosa), acute bacterial sinusitis, nasal foreign body, inhaled foreign body, pertussis, structural abnormalities of the nose or sinuses, influenza, and bacterial pharyngitis or tonsillitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22281/abstract/2,7,40\">",
"     2,7,40",
"    </a>",
"    ]. These conditions usually can be differentiated from the common cold by history and physical examination.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allergic, seasonal, or vasomotor rhinitis; rhinitis medicamentosa &ndash; Historical features usually differentiate these disorders from the common cold (eg, previous history, pattern of onset, exposure, etc) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=see_link\">",
"       \"An overview of rhinitis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Acute bacterial sinusitis &ndash; Patients with acute bacterial sinusitis may complain of facial pain; acute bacterial sinusitis is differentiated from the common cold by the persistence, increased severity, or worsening of symptoms (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H9#H9\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Acute bacterial rhinosinusitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Nasal foreign body &ndash; Clinical features suggestive of nasal foreign body include unilateral, fetid, purulent, or blood-stained nasal discharge; the foreign body usually can be seen with anterior rhinoscopy after suctioning purulent secretions (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/21/17752?source=see_link\">",
"       \"Diagnosis and management of intranasal foreign bodies\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Inhaled foreign body &ndash; Clinical features suggestive of inhaled foreign body may include acute onset of cough, a choking episode, monophonic wheezing, and localized decreased air entry (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/33/2585?source=see_link&amp;anchor=H3#H3\">",
"       \"Airway foreign bodies in children\", section on 'Presentation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pertussis &ndash; Pertussis classically begins with mild cough and coryza (catarrhal phase); however the cough gradually increases and becomes paroxysmal (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical features and diagnosis of Bordetella pertussis infection in infants and children\", section on 'Classical presentation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Structural abnormalities of the nose or sinuses &ndash; Structural abnormalities of the nose or sinuses may result in nasal congestion or stuffiness; these lesions usually are not associated with other manifestations of the common cold (eg, cough, sore throat, fever)",
"     </li>",
"     <li>",
"      Influenza &ndash; Although influenza virus may cause the common cold, it usually causes more severe illness; abrupt onset of fever (often &gt;39&deg;C [102.2&deg;F]), headache, myalgia, and malaise in addition to cough, sore throat, and rhinitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Bacterial pharyngitis or tonsillitis &ndash; Group A streptococcal tonsillopharyngitis usually is not accompanied by nasal symptoms, which are the predominant manifestation of the common cold in children (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H3#H3\">",
"       \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Bacteria'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=see_link\">",
"       \"Patient information: Giving your child over-the-counter medicines (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=see_link\">",
"       \"Patient information: Cough in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40643?source=see_link\">",
"       \"Patient information: The common cold in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199066407\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The common cold is an acute, self-limiting viral syndrome of the upper respiratory tract, involving, to variable degrees, sneezing, nasal congestion and discharge, sore throat, cough, low grade fever, headache, and malaise. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The symptoms of the common cold can be caused by a variety of viruses (",
"      <a class=\"graphic graphic_table graphicRef56841 \" href=\"UTD.htm?29/59/30652\">",
"       table 1",
"      </a>",
"      ). Rhinoviruses cause up to 50 percent of colds in children and adults. Other common causes of colds in preschool children include respiratory syncytial virus (RSV), influenza viruses, parainfluenza viruses, and adenoviruses. (See",
"      <a class=\"local\" href=\"#H199066514\">",
"       'Virology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of colds are transmitted by hand contact; cold-inducing viruses may remain viable on human skin for at least two hours and on inanimate surfaces for a day. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children younger than six years have an average of six to eight colds per year with typical symptom duration of 14 days. Nasal congestion, nasal discharge, and cough are the predominant symptoms (",
"      <a class=\"graphic graphic_figure graphicRef65898 \" href=\"UTD.htm?4/28/4559\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H714086587\">",
"       'Symptoms and signs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abnormal middle ear pressure occurs frequently during the course of the common cold, particularly during the first week. Radiographic abnormalities of the paranasal sinuses (rhinosinusitis) also occur frequently during the course of the common cold and resolves without antibiotic treatment. (See",
"      <a class=\"local\" href=\"#H374394953\">",
"       'Middle ear abnormalities'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H374394904\">",
"       'Radiographic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of the common cold include acute otitis media, acute bacterial sinusitis, asthma exacerbation, and lower respiratory tract disease. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of the common cold is made clinically, based upon history and examination findings, including exposure to someone with a cold, nasal congestion, nasal discharge, sore throat, fever (in young children), anterior cervical adenopathy, and erythema of nasal mucosa and oropharynx. Other diagnoses should be considered if the child has fever &gt;39&deg;C (102.2&deg;F), ill-appearance, absence of nasal symptoms, oral mucosal lesions, wheezing, focal findings on lung examination, hemoptysis, or features of a chronic respiratory disorder (eg, failure to thrive, finger clubbing, over-inflated chest, chest deformity, atopy). Laboratory tests are not helpful in making the diagnosis. (See",
"      <a class=\"local\" href=\"#H199066638\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of the common cold includes other causes of rhinitis (allergic, seasonal, vasomotor, rhinitis medicamentosa), acute bacterial sinusitis, nasal foreign body, inhaled foreign body, pertussis, structural abnormalities of the nose or sinuses, influenza, and bacterial pharyngitis or tonsillitis. These conditions usually can be differentiated from the common cold by history and physical examination. (See",
"      <a class=\"local\" href=\"#H199066646\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/1\">",
"      Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/2\">",
"      Heikkinen T, J&auml;rvinen A. The common cold. Lancet 2003; 361:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/3\">",
"      Lee GM, Friedman JF, Ross-Degnan D, et al. Misconceptions about colds and predictors of health service utilization. Pediatrics 2003; 111:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/4\">",
"      Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med 2002; 44:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/5\">",
"      Boivin G, Abed Y, Pelletier G, et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002; 186:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/6\">",
"      Esper F, Boucher D, Weibel C, et al. Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 2003; 111:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/7\">",
"      Pappas DE, Hendley JO. The common cold and decongestant therapy. Pediatr Rev 2011; 32:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/8\">",
"      Kirkpatrick GL. The common cold. Prim Care 1996; 23:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/9\">",
"      Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther 2002; 24:1987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/10\">",
"      Sung RY, Murray HG, Chan RC, et al. Seasonal patterns of respiratory syncytial virus infection in Hong Kong: a preliminary report. J Infect Dis 1987; 156:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/11\">",
"      Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Semin Pediatr Infect Dis 1998; 9:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/12\">",
"      Hendley JO, Gwaltney JM Jr. Mechanisms of transmission of rhinovirus infections. Epidemiol Rev 1988; 10:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/13\">",
"      Gwaltney JM Jr, Moskalski PB, Hendley JO. Hand-to-hand transmission of rhinovirus colds. Ann Intern Med 1978; 88:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/14\">",
"      Gwaltney JM Jr, Hendley JO. Rhinovirus transmission: one if by air, two if by hand. Am J Epidemiol 1978; 107:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/15\">",
"      Hendley JO, Wenzel RP, Gwaltney JM Jr. Transmission of rhinovirus colds by self-inoculation. N Engl J Med 1973; 288:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/16\">",
"      Gwaltney JM Jr, Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol 1982; 116:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/17\">",
"      Winther B, McCue K, Ashe K, et al. Environmental contamination with rhinovirus and transfer to fingers of healthy individuals by daily life activity. J Med Virol 2007; 79:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/18\">",
"      Winther B, McCue K, Ashe K, et al. Rhinovirus contamination of surfaces in homes of adults with natural colds: transfer of virus to fingertips during normal daily activities. J Med Virol 2011; 83:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/19\">",
"      Pappas DE, Hendley JO, Schwartz RH. Respiratory viral RNA on toys in pediatric office waiting rooms. Pediatr Infect Dis J 2010; 29:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/20\">",
"      Hendley JO, Gwaltney JM Jr. Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection. J Clin Virol 2004; 30:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/21\">",
"      Douglas RG Jr, Cate TR, Gerone PJ, Couch RB. Quantitative rhinovirus shedding patterns in volunteers. Am Rev Respir Dis 1966; 94:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/22\">",
"      Hendley JO. The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis 1998; 26:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/23\">",
"      Bardin PG, Johnston SL, Sanderson G, et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol 1994; 10:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/24\">",
"      Arruda E, Boyle TR, Winther B, et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis 1995; 171:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/25\">",
"      Turner RB, Weingand KW, Yeh CH, Leedy DW. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 1998; 26:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/26\">",
"      Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993; 265:L472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/27\">",
"      Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/28\">",
"      Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988; 157:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/29\">",
"      Winther B, Brofeldt S, Christensen B, Mygind N. Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired common colds. Acta Otolaryngol 1984; 97:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/30\">",
"      Winther B, Farr B, Turner RB, et al. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl 1984; 413:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/31\">",
"      Winther B, Brofeldt S, Gr&oslash;nborg H, et al. Study of bacteria in the nasal cavity and nasopharynx during naturally acquired common colds. Acta Otolaryngol 1984; 98:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/32\">",
"      Naclerio RM, Proud D, Kagey-Sobotka A, et al. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatr Infect Dis J 1988; 7:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/33\">",
"      Proud D, Reynolds CJ, Lacapra S, et al. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988; 137:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/34\">",
"      Winther B, Gwaltney JM, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 1990; 141:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/35\">",
"      Pappas DE, Hendley JO, Hayden FG, Winther B. Symptom profile of common colds in school-aged children. Pediatr Infect Dis J 2008; 27:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/36\">",
"      Wald ER, Dashefsky B, Byers C, et al. Frequency and severity of infections in day care. J Pediatr 1988; 112:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/37\">",
"      Ball TM, Holberg CJ, Aldous MB, et al. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med 2002; 156:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/38\">",
"      Aronson MD, Weiss ST, Ben RL, Komaroff AL. Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA 1982; 248:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/39\">",
"      Kelly LF. Pediatric cough and cold preparations. Pediatr Rev 2004; 25:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/40\">",
"      Shields MD, Bush A, Everard ML, et al. BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax 2008; 63 Suppl 3:iii1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/41\">",
"      Winther B, Hayden FG, Arruda E, et al. Viral respiratory infection in schoolchildren: effects on middle ear pressure. Pediatrics 2002; 109:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/42\">",
"      Elkhatieb A, Hipskind G, Woerner D, Hayden FG. Middle ear abnormalities during natural rhinovirus colds in adults. J Infect Dis 1993; 168:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/43\">",
"      Randall JE, Hendley JO. A decongestant-antihistamine mixture in the prevention of otitis media in children with colds. Pediatrics 1979; 63:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/44\">",
"      Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994; 330:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/45\">",
"      Manning SC, Biavati MJ, Phillips DL. Correlation of clinical sinusitis signs and symptoms to imaging findings in pediatric patients. Int J Pediatr Otorhinolaryngol 1996; 37:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/46\">",
"      Gwaltney JM Jr, Hendley JO, Phillips CD, et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000; 30:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/47\">",
"      Winther B, Alper CM, Mandel EM, et al. Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season. Pediatrics 2007; 119:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/48\">",
"      Revai K, Dobbs LA, Nair S, et al. Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age. Pediatrics 2007; 119:e1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/49\">",
"      Armengol CE, Hendley JO, Winther B. Occurrence of acute otitis media during colds in children younger than four years. Pediatr Infect Dis J 2011; 30:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/50\">",
"      Hendley JO. Clinical practice. Otitis media. N Engl J Med 2002; 347:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/51\">",
"      Butler CC, Hood K, Kinnersley P, et al. Predicting the clinical course of suspected acute viral upper respiratory tract infection in children. Fam Pract 2005; 22:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22281/abstract/52\">",
"      Hay AD, Fahey T, Peters TJ, Wilson A. Predicting complications from acute cough in pre-school children in primary care: a prospective cohort study. Br J Gen Pract 2004; 54:9.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5978 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-41F16B85B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22281=[""].join("\n");
var outline_f21_48_22281=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H199066407\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199066514\">",
"      VIROLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199069241\">",
"      Immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199066715\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Seasonal patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199066530\">",
"      Period of infectivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199067084\">",
"      Incubation period",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H647321191\">",
"      Frequency and duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H714086587\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H565532947\">",
"      - Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H565532988\">",
"      - Fever",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H565532995\">",
"      - Nasal manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H565533016\">",
"      - Cough",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H565533002\">",
"      - Other symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H374394953\">",
"      Middle ear abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H374394904\">",
"      Radiographic features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199066547\">",
"      Acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Asthma exacerbation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Sinusitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Lower respiratory tract disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199066638\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199066646\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199066407\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5978\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5978|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/28/4559\" title=\"figure 1\">",
"      Colds symptom profile",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5978|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/59/30652\" title=\"table 1\">",
"      Virology of the common cold",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/33/2585?source=related_link\">",
"      Airway foreign bodies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=related_link\">",
"      An overview of rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=related_link\">",
"      Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=related_link\">",
"      Bronchiolitis in infants and children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26010?source=related_link\">",
"      Chronic asthma in children younger than 12 years: Evaluation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=related_link\">",
"      Clinical features and diagnosis of Bordetella pertussis infection in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=related_link\">",
"      Clinical features and diagnosis of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43529?source=related_link\">",
"      Clinical features, evaluation, and diagnosis of croup",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20760?source=related_link\">",
"      Conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=related_link\">",
"      Coronaviruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/21/17752?source=related_link\">",
"      Diagnosis and management of intranasal foreign bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=related_link\">",
"      Epidemiology and etiology of epistaxis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=related_link\">",
"      Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=related_link\">",
"      Human metapneumovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=related_link\">",
"      Parainfluenza viruses in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=related_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=related_link\">",
"      Patient information: Giving your child over-the-counter medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40643?source=related_link\">",
"      Patient information: The common cold in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=related_link\">",
"      The common cold in adults: Diagnosis and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=related_link\">",
"      The common cold in adults: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13146?source=related_link\">",
"      The common cold in children: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=related_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_48_22282="Epidemiology and clinical manifestations of Cushing's syndrome";
var content_f21_48_22282=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and clinical manifestations of Cushing's syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22282/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22282/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22282/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22282/contributors\">",
"     Andre Lacroix, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/48/22282/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/48/22282/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/48/22282/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms and signs of Cushing's syndrome result directly from chronic exposure to excess glucocorticoid. Establishing the diagnosis is often difficult because none of the symptoms or signs are pathognomonic of the syndrome. There is a large spectrum of manifestations from subclinical to overt syndrome depending on duration and intensity of excess steroid production. Furthermore, some of them (such as obesity, hypertension, and glucose intolerance) are common in individuals who do not have adrenal hyperfunction. An important clinical clue to the presence of glucocorticoid excess is the",
"    <strong>",
"     simultaneous development and increasing severity",
"    </strong>",
"    of several of these symptoms.",
"   </p>",
"   <p>",
"    The major manifestations of Cushing's syndrome will be reviewed here. The diagnosis and treatment of this disorder and Cushing's syndrome during pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21913?source=see_link\">",
"     \"Establishing the diagnosis of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31225?source=see_link\">",
"     \"Establishing the cause of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/63/1016?source=see_link\">",
"     \"Overview of the treatment of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4725?source=see_link\">",
"     \"Cushing's syndrome in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675336\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the incidence of Cushing's syndrome are imprecise and underestimate the incidence of iatrogenic Cushing's syndrome, undiagnosed mild hypercortisolism, and the ectopic ACTH syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675624\">",
"    <span class=\"h2\">",
"     Iatrogenic Cushing's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 10 million Americans receive pharmacologic doses of glucocorticoids each year, so iatrogenic Cushing's syndrome must be more common than any other cause, but is seldom reported. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link&amp;anchor=H7#H7\">",
"     \"Major side effects of systemic glucocorticoids\", section on 'Cushingoid appearance and weight gain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675631\">",
"    <span class=\"h2\">",
"     Ectopic ACTH syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is probably the second most common cause of Cushing's syndrome, but is often not diagnosed. About 1 percent of patients with small-cell lung cancer have ectopic ACTH syndrome; small-cell lung carcinoma causes half of all cases of the syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/1\">",
"     1",
"    </a>",
"    ]. The incidence of small-cell lung carcinoma has decreased, but there are still approximately 30,000 new cases annually in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/2\">",
"     2",
"    </a>",
"    ]. Therefore, one could expect approximately 300 new cases of ectopic ACTH syndrome per year. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=see_link&amp;anchor=H9#H9\">",
"     \"Causes and pathophysiology of Cushing's syndrome\", section on 'Ectopic ACTH syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675645\">",
"    <span class=\"h2\">",
"     Cushing's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pituitary ACTH-dependent Cushing's syndrome is five to six times more common than Cushing's syndrome caused by benign and malignant adrenal tumors combined [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus the incidence of Cushing's disease may be 5 to 25 per million per year. However, the reported incidence was much lower (1.2 to 2.4 per million per year) in one population-based study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=see_link&amp;anchor=H8#H8\">",
"     \"Causes and pathophysiology of Cushing's syndrome\", section on 'Cushing's disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86477002\">",
"    <span class=\"h2\">",
"     Adrenal tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal masses are discovered incidentally at autopsy or by radiographic studies in 1.3 to 8.7 percent of adults, more than 99 percent of whom do not present with symptomatic adrenal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/6\">",
"     6",
"    </a>",
"    ]. Adrenal carcinoma and adenoma cause a similar number of cases of Cushing's syndrome in most series. However, a large preponderance of Cushing's syndrome caused by adrenal adenomas has been described in Hokkaido, Japan, and in Italy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The incidence of adrenal carcinoma is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/8\">",
"     8",
"    </a>",
"    ], but is estimated to be 0.2 to 2 per million per year [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=see_link\">",
"     \"Clinical presentation and evaluation of adrenocortical tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All other causes of Cushing's syndrome are extremely rare, including Cushing's syndrome during pregnancy and Cushing&rsquo;s syndrome due to either ACTH-independent macronodular adrenal hyperplasia or primary pigmented nodular adrenocortical disease, and are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4725?source=see_link\">",
"     \"Cushing's syndrome in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/45/730?source=see_link\">",
"     \"Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/35/22072?source=see_link\">",
"     \"Cushing's syndrome due to primary pigmented nodular adrenocortical disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675861\">",
"    <span class=\"h2\">",
"     Sex-related incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sex-related distribution of Cushing's syndrome varies with the cause.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Men had a three times greater incidence of the ectopic ACTH syndrome 30 years ago, but the increasing incidence of lung cancer in cigarette-smoking women has narrowed that margin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=see_link&amp;anchor=H2#H2\">",
"       \"Pathobiology and staging of small cell carcinoma of the lung\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Women are three to eight times more likely than men to develop Cushing's disease [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/3\">",
"       3",
"      </a>",
"      ], about three times more likely to have either benign or malignant adrenal tumors, and about four to five times more likely to have Cushing's syndrome associated with an adrenal tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/3,10-12\">",
"       3,10-12",
"      </a>",
"      ]. The reasons for this preponderance in women are unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675868\">",
"    <span class=\"h2\">",
"     Age-related incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The age at presentation varies depending upon the cause of hypercortisolism.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The age at which the ectopic ACTH syndrome develops parallels the development of lung carcinoma, increasing rapidly after age 50 years. Ectopic ACTH secretion due to carcinoid tumors can occur at earlier ages but is rare in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=see_link&amp;anchor=H2#H2\">",
"       \"Pathobiology and staging of small cell carcinoma of the lung\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cushing's disease occurs mainly in women aged 25 to 45 years. It is unusual in children, but still accounts for about one-third of cases of childhood Cushing's syndrome, occurring mostly after puberty. In two small studies reporting on about 20 prepubertal children, boys were affected more often than girls (18:2) while 36 of 53 adolescents with Cushing's disease were female [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=see_link&amp;anchor=H8#H8\">",
"       \"Causes and pathophysiology of Cushing's syndrome\", section on 'Cushing's disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Adrenal tumors have a bimodal age distribution, with small peaks in the first decade of life for both adenomas and carcinomas and major peaks at about 50 years for adenomas and 40 years for carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/11,15\">",
"     11,15",
"    </a>",
"    ]. Adrenal carcinoma is the cause of one-half of all cases of childhood Cushing's syndrome, and adenoma accounts for another one-sixth [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/16\">",
"     16",
"    </a>",
"    ]. Girls are affected slightly more often than boys. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=see_link\">",
"     \"Clinical presentation and evaluation of adrenocortical tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major symptoms and signs of Cushing's syndrome are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef69266 \" href=\"UTD.htm?17/39/18044\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. An important clinical clue to the presence of glucocorticoid excess is the simultaneous development and increasing severity of several of these symptoms. Symptoms that are most suggestive of the presence of hypercortisolism include supraclavicular fat pads, skin atrophy, wide purplish striae, and proximal muscle weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/20\">",
"     20",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p>",
"    The relative severity of symptoms varies, being determined by the following factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The degree and duration of hypercortisolism.",
"     </li>",
"     <li>",
"      The presence or absence of androgen excess, because hypercortisolism alone causes neither hirsutism nor pustular acne. When present in patients with pure glucocorticoid excess (ie, adrenal adenomas), these features often pre-date the development of Cushing&rsquo;s syndrome.",
"     </li>",
"     <li>",
"      The cause of the hypercortisolism (because hyperpigmentation is caused by increased secretion of corticotropin [ACTH]) and androgen excess occurs only in women with adrenal cancer or ACTH-stimulated hyperandrogenism (the adrenal gland being a major source of androgen production in women but not men). Adrenal adenomas generally secrete only glucocorticoid.",
"     </li>",
"     <li>",
"      Adrenal carcinoma or the ectopic ACTH syndrome can cause tumor-related symptoms that may overshadow the effects of hypercortisolism (such as weight loss instead of weight gain).",
"     </li>",
"     <li>",
"      In patients with adrenal adenomas, both the degree of hypercortisolemia and many of the clinical manifestations of Cushing's syndrome tend to be less severe in patients &gt;50 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/18\">",
"       18",
"      </a>",
"      ]. Many patients with incidentally discovered adrenal adenomas have subclinical Cushing's syndrome (mild hypercortisolism without clinical manifestations of Cushing's syndrome), but glucose intolerance and hypertension are common [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18569?source=see_link&amp;anchor=H18#H18\">",
"       \"The adrenal incidentaloma\", section on 'Subclinical Cushing's syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Progressive obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common feature of patients with Cushing's syndrome is progressive central (centripetal) obesity (",
"    <a class=\"graphic graphic_picture graphicRef82114 \" href=\"UTD.htm?34/48/35585\">",
"     picture 1",
"    </a>",
"    ), usually involving the face, neck, trunk, abdomen (",
"    <a class=\"graphic graphic_picture graphicRef50564 \" href=\"UTD.htm?18/57/19344\">",
"     picture 2",
"    </a>",
"    ), and, internally, spinal canal and mediastinum [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. The extremities are usually spared and may be wasted. Some authors report generalized obesity in a majority of adults with Cushing&rsquo;s syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with Cushing's syndrome almost invariably have generalized obesity and growth retardation; the latter may be the first indication of glucocorticoid excess. As a result, any child whose weight rises and height falls in percentile rank as compared with age-matched normal children should be considered to have Cushing's syndrome until proven otherwise (",
"    <a class=\"graphic graphic_figure graphicRef87007 \" href=\"UTD.htm?42/17/43288\">",
"     figure 1",
"    </a>",
"    ). These abnormalities both improve after successful treatment of patients whose bones have not yet fused [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fat can also accumulate in the following areas in patients with Cushing's syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fat accumulation in the cheeks results in a \"moon\" face that sometimes obscures the ears when a patient is examined from the front (",
"      <a class=\"graphic graphic_picture graphicRef77261 \" href=\"UTD.htm?9/12/9423\">",
"       picture 3",
"      </a>",
"      ). Fat deposition in the temporal fossae also contributes to facial rounding.",
"     </li>",
"     <li>",
"      A \"buffalo hump\" or dorsocervical fat pad is common and is usually consistent with the general degree of obesity (",
"      <a class=\"graphic graphic_picture graphicRef82478 \" href=\"UTD.htm?22/22/22886\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Enlarged fat pads that fill the supraclavicular fossae and obscure the clavicles is one of the most specific signs of Cushing's syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/20\">",
"       20",
"      </a>",
"      ], although they occasionally occur in exogenous obesity. The bulging supraclavicular fat pads make the neck appear thick and shortened (",
"      <a class=\"graphic graphic_picture graphicRef77261 \" href=\"UTD.htm?9/12/9423\">",
"       picture 3",
"      </a>",
"      ). Retroorbital fat deposition may result in exophthalmos, which is present in up to 5 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/24,25\">",
"       24,25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The degree of fat accumulation in Cushing's syndrome is variable. Patients who diet and exercise rigorously may have little or no weight gain, facial rounding, or central weight redistribution. Other patients with no weight gain still have central weight redistribution. The cause of abdominal fat may be caused by cortisol-induced downregulation of adenosine monophosphate-activated protein kinase (AMPK), which regulates lipid and carbohydrate metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with Cushing's syndrome have higher serum leptin concentrations than obese subjects with a similar body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/27\">",
"     27",
"    </a>",
"    ]. Leptin secretion does not respond to changes in plasma ACTH or serum cortisol concentrations, but it does appear to vary according to changes in fat mass and peripheral insulin resistance (and therefore serum insulin concentrations), as it does in other obese subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dermatologic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many changes in the skin and subcutaneous tissue occur in patients with Cushing's syndrome. Unlike most other symptoms and signs associated with Cushing's syndrome, which can occur alone or in combination in normal subjects and patients with pseudo-Cushing's states, the dermatologic changes characteristic of Cushing's syndrome seldom occur in other subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/20,29\">",
"     20,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Skin&nbsp;atrophy &mdash; The skin usually atrophies, the stratum corneum is thinned, and there is loss of subcutaneous fat to a sufficient degree that subcutaneous blood vessels may be seen [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/30\">",
"       30",
"      </a>",
"      ]. The skin eventually becomes fragile due to these changes and, in extreme cases, peels off after being covered with adhesive tape. Minor wounds heal slowly, and surgical wounds may dehisce. Such changes should be considered in the context of gender and age differences in skin thickness, with men and younger individuals having greater skin thickness.",
"     </li>",
"     <li>",
"      Easy bruisability &mdash; Loss of subcutaneous connective tissue due to the catabolic effects of glucocorticoid results in easy bruising after minimal, often unremembered injury (",
"      <a class=\"graphic graphic_picture graphicRef65564 \" href=\"UTD.htm?14/47/15103\">",
"       picture 5",
"      </a>",
"      ). Extensive ecchymoses at venipuncture sites are also common, and it is often difficult to maintain intravenous lines without fluid infiltration into the surrounding tissues. As a result, patients with Cushing's syndrome are sometimes thought to have senile purpura or a bleeding diathesis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Striae &mdash; Purple striae occur as the fragile skin stretches due to the enlarging trunk, breasts, and abdomen (",
"      <a class=\"graphic graphic_picture graphicRef67682 \" href=\"UTD.htm?6/51/6975\">",
"       picture 6",
"      </a>",
"      ). The striae appear as wide, reddish-purple streaks because the increasingly thin skin does not hide the color of venous blood in the underlying dermis. Striae occur most often in younger patients, can be numerous, and are most common on the abdomen and lower flanks; however, they can also occur on the breasts, hips, buttocks, shoulders, upper thighs, upper arms, and axillae [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fungal infections &mdash; Cutaneous fungal infections, especially tinea versicolor, are often found on the trunk. Some patients have fungal infections of the nails, but oral candidiasis is rare.",
"     </li>",
"     <li>",
"      Hyperpigmentation &mdash; Hyperpigmentation is induced by increased ACTH, not cortisol, secretion. ACTH is the principal pigmentary hormone in humans. It acts via binding to melanocyte-stimulating hormone receptors [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/33\">",
"       33",
"      </a>",
"      ]. The degree of hyperpigmentation is dependent upon both the duration and the degree of increase in ACTH secretion.",
"      <br/>",
"      <br/>",
"      Hyperpigmentation occurs most often in patients with the ectopic ACTH syndrome, less often in those with pituitary overproduction of ACTH, and not at all in patients with adrenal tumors in whom ACTH secretion is suppressed.",
"      <br/>",
"      <br/>",
"      Hyperpigmentation may be generalized, but is most conspicuous in areas exposed to light (such as the face, neck, and back of the hands) or to chronic mild trauma, friction, or pressure (such as the elbows, knees, spine, knuckles, waist [belt], midriff [girdle], and shoulders [brassiere straps]) (",
"      <a class=\"graphic graphic_picture graphicRef70693 graphicRef61260 \" href=\"UTD.htm?13/6/13415\">",
"       picture 7A-B",
"      </a>",
"      ). Patchy pigmentation may occur on the inner surface of lips and the buccal mucosa along the line of dental occlusion (",
"      <a class=\"graphic graphic_picture graphicRef56401 \" href=\"UTD.htm?24/55/25456\">",
"       picture 8",
"      </a>",
"      ). The hyperpigmentation is less pronounced than in patients with chronic primary adrenal insufficiency.",
"      <br/>",
"      <br/>",
"      Acanthosis nigricans also can be present in the axillae and around the neck.",
"      <br/>",
"      <br/>",
"      Surgical or traumatic scars that form when plasma ACTH concentrations are markedly elevated are permanently pigmented. In comparison, scars incurred before ACTH hypersecretion or after it is reduced are not pigmented (",
"      <a class=\"graphic graphic_picture graphicRef62900 \" href=\"UTD.htm?21/48/22273\">",
"       picture 9",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Menstrual irregularities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Menstrual irregularities are common in women with Cushing's syndrome. In one series of 45 women with newly diagnosed Cushing's disease, 80 percent had abnormal menstrual cycles; 31 percent had oligomenorrhea, 33 percent had amenorrhea, and the remainder had excess or variable menses [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/34\">",
"     34",
"    </a>",
"    ]. The menstrual abnormalities correlated with increased serum cortisol and decreased serum estradiol concentrations, but not with serum androgen concentrations. The menstrual irregularities may be due to suppression of secretion of gonadotropin-releasing hormone by hypercortisolemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Signs of adrenal androgen excess",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major source of androgens in women is the adrenal glands [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/36\">",
"     36",
"    </a>",
"    ]. As a result, women with Cushing's syndrome often have signs of androgen excess [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/37\">",
"     37",
"    </a>",
"    ]. In contrast, the major source of androgens in men is the testes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/38\">",
"     38",
"    </a>",
"    ]. Thus, men with Cushing's syndrome do not have signs of androgen excess because cortisol has no androgenic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs of androgen excess in Cushing's syndrome are most common in women with adrenal carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/10,15\">",
"     10,15",
"    </a>",
"    ]. These tumors usually secrete large amounts of androgenic precursors because they are inefficient at converting cholesterol to cortisol [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. In comparison, signs of androgen excess are usually mild in women with ACTH-dependent Cushing's syndrome and do not occur in women with adrenal adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Androgen excess in affected women can cause the following symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hirsutism, which is usually mild and limited to the face, but can be generalized. Downy sideburns and increased hair on the upper lip and under the chin are most common (",
"      <a class=\"graphic graphic_picture graphicRef77261 \" href=\"UTD.htm?9/12/9423\">",
"       picture 3",
"      </a>",
"      ). The scalp hair often becomes thin, but temporal balding is rare.",
"     </li>",
"     <li>",
"      Oily facial skin and acne on the face, neck, or shoulders.",
"     </li>",
"     <li>",
"      Increased libido.",
"     </li>",
"     <li>",
"      Virilization, including temporal balding, deepening voice, male body habitus, male escutcheon, and clitoral hypertrophy, usually occurs only in girls or women with extremely high serum concentrations of androgens due to an adrenal carcinoma. Prepubertal males may develop premature puberty (",
"      <a class=\"graphic graphic_picture graphicRef55622 \" href=\"UTD.htm?37/19/38207\">",
"       picture 10",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Proximal muscle wasting and weakness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weakness and proximal muscle wasting are common in Cushing's syndrome, being induced by the catabolic effects of excess glucocorticoid on skeletal muscle (",
"    <a class=\"graphic graphic_picture graphicRef64072 \" href=\"UTD.htm?0/38/623\">",
"     picture 11",
"    </a>",
"    ). As a result, many patients cannot rise from a squatting position without assistance; patients with more severe disease may be unable to climb stairs or get up from a deep chair. The catabolic effects of cortisol are amplified by physical inactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=see_link\">",
"     \"Glucocorticoid-induced myopathy\"",
"    </a>",
"    .) Muscle wasting and weakness are rare in patients with pseudo-Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/20,24,25,27,29\">",
"     20,24,25,27,29",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p>",
"    Hypokalemia, due to increased mineralocorticoid activity, can accentuate the weakness in patients with severe hypercortisolism. On the other hand, a high-protein diet and exercise may improve muscle wasting and increase strength.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Bone loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoporosis is common in patients with Cushing's syndrome. It is caused by decreased intestinal calcium absorption, decreased bone formation, increased bone resorption, and decreased renal calcium reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. It can be demonstrated by densitometry of the lumbar vertebrae even in young patients. Pathologic fractures may occur, often resulting in severe skeletal pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42855?source=see_link\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following skeletal abnormalities may be seen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early reports estimated that vertebral compression fractures occur in approximately 20 percent of patients with Cushing's syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. However, in a study of 80 patients with Cushing's syndrome, prevalence was considerably higher at 76 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pathologic rib and long bone fractures.",
"     </li>",
"     <li>",
"      Osteonecrosis (aseptic necrosis) of the femoral heads and rarely the humeral heads, usually only with chronic high-dose glucocorticoid therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/48\">",
"       48",
"      </a>",
"      ]. Rarely, osteonecrosis of the femoral head is the presenting manifestation of Cushing's syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=see_link\">",
"       \"Osteonecrosis (avascular necrosis of bone)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low back pain is very common and is attributed to osteoporosis, vertebral compression, muscle wasting, and the lordotic posture resulting from weight gain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Increased bone resorption can also lead to hypercalciuria and renal calculi [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/50\">",
"     50",
"    </a>",
"    ]. Hypercalcemia is very rare.",
"   </p>",
"   <p>",
"    Bone mineral density improves in adults and children after successful treatment of Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/19,51\">",
"     19,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Subclinical hypercortisolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even patients with mild chronic hypercortisolism, such as women who have adrenal incidentalomas causing slightly increased cortisol secretion but no other clinical manifestations of Cushing's syndrome (ie, subclinical Cushing's syndrome), may have increased bone turnover, decreased bone mineral density, and vertebral fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18569?source=see_link&amp;anchor=H18#H18\">",
"     \"The adrenal incidentaloma\", section on 'Subclinical Cushing's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Glucose intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucose intolerance is common in Cushing's syndrome. It is primarily due to stimulation of gluconeogenesis by cortisol and peripheral insulin resistance caused by obesity, but direct suppression of insulin release also may contribute. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overt hyperglycemia occurs in only 10 to 15 percent of patients, usually those with a family history of type 2 diabetes mellitus. Diabetic ketoacidosis is rare and, if present, usually indicates unsuspected type 1 diabetes exacerbated by hypercortisolemia.",
"   </p>",
"   <p>",
"    Poorly controlled hyperglycemia in an obese patient may be a clue to the presence of Cushing's syndrome. One report, for example, found that 3 percent of such patients had Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/52\">",
"     52",
"    </a>",
"    ]. In a prospective study of 200 obese patients with type 2 diabetes and no symptoms of Cushing's syndrome, four patients (2 percent) were identified as having occult Cushing's syndrome (three with Cushing's disease, and one with an adrenal adenoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/53\">",
"     53",
"    </a>",
"    ]. However, a subsequent study of 201 patients did not identify any with Cushing&rsquo;s syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/54\">",
"     54",
"    </a>",
"    ]. Thus, it is not recommended to screen diabetic patients unless they have other features of the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with Cushing's syndrome who have hyperglycemia should be treated like any other patient with type 2 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36458?source=see_link\">",
"     \"Overview of medical care in adults with diabetes mellitus\"",
"    </a>",
"    .) The hyperglycemia becomes much easier to control and may completely remit if the hypercortisolism is reversed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increased urinary albumin excretion appears to be common in Cushing's syndrome and it is reversible. In a study of 13 patients, 80 percent had increased urinary albumin excretion, but neither the presence nor the degree of albuminuria was correlated with blood pressure or fasting plasma glucose concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/57\">",
"     57",
"    </a>",
"    ]. Kidney biopsies in three patients with microalbuminuria showed normal glomeruli with no evidence of diabetic or hypertensive nephropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hypertension and cardiovascular risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular disease, in particular moderate diastolic hypertension, is a major cause of morbidity and death in patients with Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/24,45,58\">",
"     24,45,58",
"    </a>",
"    ]. The pathogenesis of hypertension is multifactorial and not fully understood; however, the following factors may be important [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased peripheral vascular sensitivity to adrenergic agonists [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/61\">",
"       61",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increased hepatic production of renin substrate (angiotensinogen)",
"     </li>",
"     <li>",
"      Activation of renal tubular type 1 (mineralocorticoid) receptors by cortisol (this mechanism applies mainly to patients with severe hypercortisolism, which is usually due to ectopic ACTH secretion) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/62,63\">",
"       62,63",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      It is also possible that cortisol has a direct cardiotoxic effect [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/64\">",
"       64",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Ectopic ACTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hypertension and hypokalemia are more prevalent in patients with ectopic ACTH [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/65\">",
"     65",
"    </a>",
"    ]. The high serum cortisol concentrations overwhelm the ability of the kidneys to convert cortisol to cortisone, resulting in activation of mineralocorticoid receptors as described above. Hypokalemia may also result from adrenal hypersecretion of mineralocorticoids such as deoxycorticosterone and corticosterone [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40838?source=see_link&amp;anchor=H9#H9\">",
"     \"Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)\", section on 'Ectopic ACTH syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One series reported heart failure in almost one-half of patients older than 40 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/45\">",
"     45",
"    </a>",
"    ], but in our experience it is rare. Dependent edema can also occur, although the mechanism is not well understood. It should not be caused by excess mineralocorticoid activity, due to the phenomenon of aldosterone escape [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features of primary aldosteronism\", section on 'Lack of edema'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although markers of cardiovascular risk, including lipid profiles, waist-to-hip ratios, and carotid artery intima medial thickness, improve in patients cured of their Cushing's disease, they may not normalize, suggesting that cured patients continue to have excess cardiovascular risk (possibly due to residual abdominal obesity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    insulin resistance) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/68,69\">",
"     68,69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study estimated cardiovascular risk in 49 patients with active Cushing's syndrome according to World Health",
"    <span class=\"nowrap\">",
"     Organization/International",
"    </span>",
"    Society of Hypertension criteria. Eighty percent of patients had a high or very high risk: 85 percent were hypertensive, 47 percent were diabetic, and 41 percent were obese [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/70\">",
"     70",
"    </a>",
"    ]. Thus, aggressive treatment of these factors is warranted.",
"   </p>",
"   <p>",
"    Treatment of hypertension in patients with Cushing's syndrome does not differ from that of patients with essential hypertension. However, blocking mineralocorticoid activity with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    may be particularly effective in patients with very high serum cortisol concentrations, especially those with hypokalemia. The hypertension usually becomes easier to control and may entirely disappear when the Cushing's syndrome is treated.",
"   </p>",
"   <p>",
"    Patients with subclinical Cushing's syndrome due to an adrenal incidentaloma may also have excess cardiovascular risk [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18569?source=see_link&amp;anchor=H18#H18\">",
"     \"The adrenal incidentaloma\", section on 'Subclinical Cushing's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Thromboembolic events",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increase in venous thromboembolism (VTE) risk has been reported in most studies of patients with Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/20,72-74\">",
"     20,72-74",
"    </a>",
"    ]. In a systematic review of 15 studies, the risk of postoperative VTE ranged from 0 to 5.6 percent (with one outlier of 20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/75\">",
"     75",
"    </a>",
"    ]. In two of the studies, the risk of VTE not related to surgery was reported to be 1.9 and 2.5 percent. Based upon the 6 to 9.7 years of follow-up in these studies, this corresponded to an incidence of 2.5 to 3.1 per 1000 person-years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/75\">",
"     75",
"    </a>",
"    ], much higher than the estimated incidence in an age- and sex-matched population (VTE incidence for 40 year old women = 0.3 per 1000 person-years) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a multicenter cohort study of patients with Cushing&rsquo;s syndrome published after the systematic review (n = 473; 360 with ACTH-dependent pituitary Cushing&rsquo;s syndrome, 113 with ACTH-independent adrenal disease), VTE rates not related to surgery were higher than reported in the systematic review, while postoperative rates were in a similar range [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/77\">",
"     77",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior to treatment, 17 patients with Cushing&rsquo;s syndrome (4 percent) had a VTE, for an incidence rate of 12.9 per 1000 person-years.",
"     </li>",
"     <li>",
"      The frequency of postoperative VTE (within three months after transsphenoidal surgery for ACTH-dependent or adrenalectomy for ACTH-independent) was 3.4 and 0 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/77\">",
"       77",
"      </a>",
"      ]. No episodes of postoperative VTE were seen in a control group of 185 patients with nonfunctioning pituitary adenomas undergoing pituitary surgery. The 3.4 percent postoperative risk in those with ACTH-dependent disease (12 events in 350 patients) translates to an incidence of 141 per 1000 person-years. No episodes of postoperative VTE were seen in a control group of 185 patients undergoing pituitary surgery for nonfunctioning adenomas.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk is possibly due to glucocorticoid-induced increases in plasma concentrations of clotting factors, especially Factor VIII and von Willebrand factor complex, and decreases in fibrinolytic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. Elevated serum homocysteine concentrations, which appear to be associated with an increased risk of cardiovascular disease and venous thrombosis, have been reported in patients with Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/78\">",
"     78",
"    </a>",
"    ]. In addition, obesity and surgery appear to contribute to the excess risk of thromboembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link\">",
"     \"Overview of homocysteine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prophylactic postoperative anticoagulation may reduce the risk of thromboembolic complications. This was illustrated in a retrospective study of 307 patients with Cushing's syndrome; post-operative prophylactic anticoagulation with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    appeared to reduce the risk of thromboembolic complications (14 of 232 patients; 6 percent) compared with a historical control group that was not anticoagulated (15 of 75 patients; 20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/73\">",
"     73",
"    </a>",
"    ]. Although further studies are needed to confirm its benefit, post-operative anticoagulation prophylaxis seems warranted at present for non-ambulatory patients. In the absence of further studies, we would not recommend postoperative anticoagulation in patients who are ambulatory.",
"   </p>",
"   <p>",
"    We also encourage our hospitalized patients to get out of bed during the day, and to walk for 15 to 20 minutes two or three times a day, if possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588675995\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cushing's syndrome is associated with considerable morbidity and increased mortality. In a population-based study of Cushing's syndrome, mortality was increased in the first year after diagnosis, even in those patients without concurrent cancer, and some of the deaths occurred before treatment could be initiated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/4\">",
"     4",
"    </a>",
"    ]. However, the standardized mortality rate in patients cured of Cushing&rsquo;s disease has not increased [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/79\">",
"     79",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Neuropsychological changes and cognition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of psychiatric disease occur in over one-half of patients with Cushing's syndrome of any etiology and are, therefore, presumably caused by excess cortisol [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/24,80,81\">",
"     24,80,81",
"    </a>",
"    ]. Some patients have psychiatric illness as the presenting symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common psychologic symptoms are [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/24,80-82\">",
"     24,80-82",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Emotional lability",
"     </li>",
"     <li>",
"      Agitated depression",
"     </li>",
"     <li>",
"      Irritability",
"     </li>",
"     <li>",
"      Anxiety",
"     </li>",
"     <li>",
"      Panic attacks",
"     </li>",
"     <li>",
"      Mild paranoia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, insomnia is often an early symptom that is thought to be caused by high serum cortisol concentrations during sleep due to absence of the normal diurnal variation in cortisol secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Depression occurs in two-thirds of patients with Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/82,84\">",
"     82,84",
"    </a>",
"    ]. Most have the increased appetite and weight gain that is usually associated with atypical depression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/82\">",
"     82",
"    </a>",
"    ]. Rarely, however, anorexia and weight loss predominate as is common in melancholic depression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/85\">",
"     85",
"    </a>",
"    ]. Severely depressed patients may also be suicidal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/24,80\">",
"     24,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, some patients appear euphoric or manic, particularly early in the course of the illness. Children tend to be overachievers, often ranking near the top of their class [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After correction of the hypercortisolism, resolution of the psychiatric symptoms is variable [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 33 patients with Cushing's syndrome, important psychopathology (predominantly atypical depression) was present in 55 percent before treatment compared with 24 percent one year after successful treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/87\">",
"       87",
"      </a>",
"      ]. There was also a significant improvement in overall mood score. However, important psychopathology developed after treatment in 4 of 17 patients who had no prior psychiatric symptoms, and one of the four became suicidal.",
"     </li>",
"     <li>",
"      Other data suggest that Cushing's disease has adverse effects on mood and social functioning that persist after surgical cure [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/89,90\">",
"       89,90",
"      </a>",
"      ]. This was illustrated in a follow-up report of 114 patients with pituitary tumors who had undergone successful pituitary surgery. The 15 patients with treated Cushing's disease had significantly worse scores on measures of psychosocial well-being and psychosocial functioning compared with patients with other tumors (nonfunctioning adenomas, macroprolactinomas, acromegaly) in whom the scores were similar [",
"      <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/89\">",
"       89",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H139159262\">",
"    <span class=\"h3\">",
"     Cognition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Learning, cognition, and memory (especially short-term memory) are impaired by hypercortisolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. Bedside assessment of these attributes may be useful in assessing the presence of hypercortisolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypercortisolism is also associated with a decrease in hippocampal volume and a general reduction in brain volume [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/91,94\">",
"     91,94",
"    </a>",
"    ]. Brain volume increases but does not always return to normal after cure of the hypercortisolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with Cushing&rsquo;s disease in remission, cognitive function may improve, but not return to baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/95,96\">",
"     95,96",
"    </a>",
"    ]. In a study of 24 patients studied before and after treatment, some, but not all, had an improvement in cognitive and memory function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/95\">",
"     95",
"    </a>",
"    ]. Improvements in the ability to remember a list of unrelated words was associated with an increase in hippocampal volume.",
"   </p>",
"   <p>",
"    One study of 11 children found a decline in IQ and cognitive performance at one year after curative surgery, in the absence of psychopathology, despite reversal of cerebral atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Infection and immune function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids inhibit immune function, thereby contributing to an increased frequency of infections. In parallel with this, there may be thymic atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/98\">",
"     98",
"    </a>",
"    ]. Nevertheless, opportunistic infections with organisms of low pathogenicity occur only in patients with severe hypercortisolemia, such as those with ectopic ACTH syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/99\">",
"     99",
"    </a>",
"    ]. In one study, patients with serum cortisol concentrations above 40",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (1100",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    urinary cortisol excretion greater than 2000",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    (5500",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    or urinary 17-OHCS excretion greater than 35",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    creatinine (96",
"    <span class=\"nowrap\">",
"     &micro;mol/g",
"    </span>",
"    creatinine) were likely to have severe infections [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/100\">",
"     100",
"    </a>",
"    ]. Bacterial infections were most common (74 percent), but opportunistic pathogens or both (42.1 and 13.8 percent, respectively) were frequent and should be considered when giving empiric antibiotic coverage to such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which glucocorticoid excess predisposes to infection is poorly understood. One mechanism may be a fall in circulating CD4 cells and decline in natural killer-cell activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/101\">",
"     101",
"    </a>",
"    ]. Perhaps the major effect is that glucocorticoids inhibit the synthesis of almost all cytokines, apparently by inducing the synthesis of I kappa B alpha, a protein that traps and thereby inactivates nuclear factor kappa B [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. The latter protein is an activator of cytokine genes and mediator of the inflammatory action of tumor necrosis factor.",
"   </p>",
"   <p>",
"    Inhibition of cytokine release has another clinically important effect with regard to infection: the associated reduction in inflammatory and febrile responses to bacterial infection may make these infections difficult to detect.",
"   </p>",
"   <p>",
"    The increased susceptibility to infection occurs despite a glucocorticoid-induced rise in the circulating neutrophil count. The granulocytosis is partly due to decreased margination and partly to a rise in circulating",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Ophthalmologic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased intraocular pressure and cataracts occur rarely as a result of endogenous Cushing&rsquo;s syndrome and are more common with exogenous glucocorticoid administration, in particular, topical steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/105-107\">",
"     105-107",
"    </a>",
"    ].",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Administration of high doses of glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although endogenous cortisol hypersecretion is relatively rare, many clinicians care for patients receiving prolonged, often high-dose glucocorticoid therapy for autoimmune disorders, such as vasculitis, systemic lupus erythematosus, and rheumatoid arthritis; for allergic disorders such as asthma; and to prevent transplant rejection. These patients have a relatively high frequency of serious glucocorticoid-induced side effects. For example, a study of patients with granulomatosis with polyangiitis (Wegener&rsquo;s) reported the following complications: opportunistic infections (which may have been due in part to concurrent therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ), cataracts (21 percent), diabetes mellitus (8 percent), osteopenia, fractures (11 percent), and aseptic necrosis of bone (3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/108\">",
"     108",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Emotional lability, hypertension, a Cushingoid habitus, enhanced appetite, and weight gain are other common side effects of glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/48/22282/abstract/109\">",
"     109",
"    </a>",
"    ]. The side effects of glucocorticoids (all routes of administration) are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=see_link\">",
"     \"Major side effects of inhaled glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/61/6099?source=see_link\">",
"       \"Patient information: Cushing's syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/19/13619?source=see_link\">",
"       \"Patient information: Cushing's syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H588676213\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Iatrogenic Cushing&rsquo;s syndrome due to pharmacologic doses of glucocorticoids is likely the most common cause of Cushing&rsquo;s syndrome followed by ectopic ACTH secretion associated with small-cell lung cancer, although in the latter condition, hypercortisolism may not be recognized because of weight loss and paraneoplastic syndromes. (See",
"      <a class=\"local\" href=\"#H588675336\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pituitary ACTH-dependent Cushing's syndrome is five to six times more common than Cushing's syndrome caused by benign and malignant adrenal tumors combined. (See",
"      <a class=\"local\" href=\"#H588675336\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An important clinical clue to the presence of glucocorticoid excess is the simultaneous development and increasing severity of multiple symptoms consistent with Cushing&rsquo;s syndrome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major symptoms and signs of Cushing's syndrome are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef69266 \" href=\"UTD.htm?17/39/18044\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Symptoms that are most suggestive of the presence of hypercortisolism include supraclavicular fat pads, skin atrophy, wide purplish striae, and proximal muscle weakness. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some of the most common manifestations of Cushing&rsquo;s syndrome, such as obesity, hypertension, and glucose intolerance are less suggestive of the presence of hypercortisolism, as they are also common in individuals who do not have adrenal hyperfunction. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other clinical manifestations are reviewed in detail above. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Orth DN. Ectopic hormone production. In: Endocrinology and metabolism, Felig P, Baxter JD, Broadus AE, Frohman LA (Eds), McGraw-Hill, New York 1987. p.1692.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/2\">",
"      Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24:4539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/3\">",
"      Carpenter PC. Diagnostic evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 1988; 17:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/4\">",
"      Lindholm J, Juul S, J&oslash;rgensen JO, et al. Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001; 86:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/5\">",
"      Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994; 40:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/6\">",
"      Ross NS. Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab Clin North Am 1994; 23:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/7\">",
"      Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999; 84:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/8\">",
"      Brennan MF. Adrenocortical carcinoma. CA Cancer J Clin 1987; 37:348.",
"     </a>",
"    </li>",
"    <li>",
"     Cutler, SJ, Young, JL. Third National Cancer Survey: incidence data. National Cancer Institute monograph 41, DHEW Publication 287. Government Printing Office, Washington, DC 1975.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/10\">",
"      Hutter AM Jr, Kayhoe DE. Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 1966; 41:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/11\">",
"      Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990; 322:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/12\">",
"      Kasperlik-Zauska AA, Migdalska BM, Zgliczyski S, Makowska AM. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 1995; 75:2587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/13\">",
"      Storr HL, Isidori AM, Monson JP, et al. Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 2004; 89:3818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/14\">",
"      Magiakou MA, Mastorakos G, Oldfield EH, et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994; 331:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/15\">",
"      Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981; 71:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/16\">",
"      Neville AM, Symington T. Bilateral adrenocortical hyperplasia in children with Cushing's syndrome. J Pathol 1972; 107:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/17\">",
"      Howlett TA, Rees LH, Besser GM. Cushing's syndrome. Clin Endocrinol Metab 1985; 14:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/18\">",
"      Katayama M, Nomura K, Ujihara M, et al. Age-dependent decline in cortisol levels and clinical manifestations in patients with ACTH-independent Cushing's syndrome. Clin Endocrinol (Oxf) 1998; 49:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/19\">",
"      Terzolo M, Pia A, Al&igrave; A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/20\">",
"      Ross EJ, Linch DC. Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982; 2:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/21\">",
"      Wajchenberg BL, Bosco A, Marone MM, et al. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab 1995; 80:2791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/22\">",
"      Koch CA, Doppman JL, Watson JC, et al. Spinal epidural lipomatosis in a patient with the ectopic corticotropin syndrome. N Engl J Med 1999; 341:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/23\">",
"      Davies JH, Storr HL, Davies K, et al. Final adult height and body mass index after cure of paediatric Cushing's disease. Clin Endocrinol (Oxf) 2005; 62:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/24\">",
"      PLOTZ CM, KNOWLTON AI, RAGAN C. The natural history of Cushing's syndrome. Am J Med 1952; 13:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/25\">",
"      Panzer SW, Patrinely JR, Wilson HK. Exophthalmos and iatrogenic Cushing's syndrome. Ophthal Plast Reconstr Surg 1994; 10:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/26\">",
"      Kola B, Christ-Crain M, Lolli F, et al. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. J Clin Endocrinol Metab 2008; 93:4969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/27\">",
"      Weise M, Abad V, Considine RV, et al. Leptin secretion in Cushing's syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone. J Clin Endocrinol Metab 1999; 84:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/28\">",
"      Schafroth U, Godang K, Ueland T, et al. Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index. J Endocrinol Invest 2000; 23:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/29\">",
"      Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998; 19:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/30\">",
"      Ferguson JK, Donald RA, Weston TS, Espiner EA. Skin thickness in patients with acromegaly and Cushing's syndrome and response to treatment. Clin Endocrinol (Oxf) 1983; 18:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/31\">",
"      Rosenberg EM, Hahn TJ, Orth DN, et al. ACTH-secreting medullary carcinoma of the thyroid presenting a severe idiopathic osteoporosis and senile purpura: report of a case and review of the literature. J Clin Endocrinol Metab 1978; 47:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/32\">",
"      Urbanic RC, George JM. Cushing's disease--18 years' experience. Medicine (Baltimore) 1981; 60:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/33\">",
"      Mountjoy KG. The human melanocyte stimulating hormone receptor has evolved to become \"super-sensitive\" to melanocortin peptides. Mol Cell Endocrinol 1994; 102:R7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/34\">",
"      Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, et al. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab 1998; 83:3083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/35\">",
"      Penezi Z, Zarkovi M, Vujovi S, et al. Gonadotropin pulsatility in Cushing's syndrome compared with polycystic ovary syndrome. Gynecol Endocrinol 2005; 20:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/36\">",
"      Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974; 39:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/37\">",
"      Kaltsas GA, Korbonits M, Isidori AM, et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol (Oxf) 2000; 53:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/38\">",
"      Hammond GL, Ruokonen A, Kontturi M, et al. The simultaneous radioimmunoassay of seven steroids in human spermatic and peripheral venous blood. J Clin Endocrinol Metab 1977; 45:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/39\">",
"      Chang CS, Kokontis J, Liao ST. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988; 240:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/40\">",
"      D'Agata R, Malozowski S, Barkan A, et al. Steroid biosynthesis in human adrenal tumors. Horm Metab Res 1987; 19:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/41\">",
"      Gr&ouml;ndal S, Eriksson B, Hagen&auml;s L, et al. Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol (Copenh) 1990; 122:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/42\">",
"      Ferrando AA, Stuart CA, Sheffield-Moore M, Wolfe RR. Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab 1999; 84:3515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/43\">",
"      Adler RA, Rosen CJ. Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 1994; 23:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/44\">",
"      Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/45\">",
"      Ross EJ, Marshall-Jones P, Friedman M. Cushing's syndrome: diagnostic criteria. Q J Med 1966; 35:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/46\">",
"      Soffer, LJ, Iannaccone, A, Gabrilove, JL. Cushing's syndrome: a study of fifty patients. Am J Med 1961; 30:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/47\">",
"      Tauchmanov&agrave; L, Pivonello R, Di Somma C, et al. Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 2006; 91:1779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/48\">",
"      Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1987; 1:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/49\">",
"      Koch CA, Tsigos C, Patronas NJ, Papanicolaou DA. Cushing's disease presenting with avascular necrosis of the hip: an orthopedic emergency. J Clin Endocrinol Metab 1999; 84:3010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/50\">",
"      LAAKE H. The action of corticosteroids on the renal reabsorption of calcium. Acta Endocrinol (Copenh) 1960; 34:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/51\">",
"      Kristo C, Jemtland R, Ueland T, et al. Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol 2006; 154:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/52\">",
"      Leibowitz G, Tsur A, Chayen SD, et al. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 1996; 44:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/53\">",
"      Catargi B, Rigalleau V, Poussin A, et al. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 2003; 88:5808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/54\">",
"      Mullan K, Black N, Thiraviaraj A, et al. Is there value in routine screening for Cushing's syndrome in patients with diabetes? J Clin Endocrinol Metab 2010; 95:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/55\">",
"      Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/56\">",
"      Chiodini I, Morelli V, Salcuni AS, et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 2010; 95:2736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/57\">",
"      Koh JM, Kim JY, Chung YE, et al. Increased urinary albumin excretion in Cushing's syndrome: remission after correction of hypercortisolaemia. Clin Endocrinol (Oxf) 2000; 52:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/58\">",
"      Cushing, H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/59\">",
"      Whitworth JA. Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int Suppl 1992; 37:S34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/60\">",
"      Saruta T, Suzuki H, Handa M, et al. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab 1986; 62:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/61\">",
"      Pirpiris M, Sudhir K, Yeung S, et al. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992; 19:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/62\">",
"      Ulick S, Wang JZ, Blumenfeld JD, Pickering TG. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1992; 74:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/63\">",
"      Mechanick JI, Morris JC. Clinical case seminar: Hypokalemia in a 52-year-old woman with non-small cell lung cancer. J Clin Endocrinol Metab 1995; 80:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/64\">",
"      Takagi S, Tanabe A, Tsuiki M, et al. Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome. Endocr J 2009; 56:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/65\">",
"      Torpy DJ, Mullen N, Ilias I, Nieman LK. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci 2002; 970:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/66\">",
"      CHRISTY NP, LARAGH JH. Pathogenesis of hypokalemic alkalosis in Cushing's syndrome. N Engl J Med 1961; 265:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/67\">",
"      Gonzalez-Campoy JM, Romero JC, Knox FG. Escape from the sodium-retaining effects of mineralocorticoids: role of ANF and intrarenal hormone systems. Kidney Int 1989; 35:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/68\">",
"      Colao A, Pivonello R, Spiezia S, et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84:2664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/69\">",
"      Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003; 88:2527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/70\">",
"      Mancini T, Kola B, Mantero F, et al. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 2004; 61:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/71\">",
"      Tauchmanov&agrave; L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002; 87:4872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/72\">",
"      Sj&ouml;berg HE, Blomb&auml;ck M, Granberg PO. Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 1976; 199:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/73\">",
"      Boscaro M, Sonino N, Scarda A, et al. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 2002; 87:3662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/74\">",
"      Small M, Lowe GD, Forbes CD, Thomson JA. Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf) 1983; 19:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/75\">",
"      Van Zaane B, Nur E, Squizzato A, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2009; 94:2743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/76\">",
"      Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/77\">",
"      Stuijver DJ, van Zaane B, Feelders RA, et al. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. J Clin Endocrinol Metab 2011; 96:3525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/78\">",
"      Terzolo M, Allasino B, Bosio S, et al. Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004; 89:3745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/79\">",
"      Swearingen B, Biller BM, Barker FG 2nd, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999; 130:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/80\">",
"      Haskett RF. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 1985; 142:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/81\">",
"      Kelly WF. Psychiatric aspects of Cushing's syndrome. QJM 1996; 89:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/82\">",
"      Loosen PT, Chambliss B, DeBold CR, et al. Psychiatric phenomenology in Cushing's disease. Pharmacopsychiatry 1992; 25:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/83\">",
"      Born J, Sp&auml;th-Schwalbe E, Schwakenhofer H, et al. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989; 68:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/84\">",
"      Dorn LD, Burgess ES, Dubbert B, et al. Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features. Clin Endocrinol (Oxf) 1995; 43:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/85\">",
"      BLACK MM, HALL R, KAY DW, KILBORN JR. ANOREXIA NERVOSA IN CUSHING'S SYNDROME. J Clin Endocrinol Metab 1965; 25:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/86\">",
"      Devoe DJ, Miller WL, Conte FA, et al. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 1997; 82:3196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/87\">",
"      Dorn LD, Burgess ES, Friedman TC, et al. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997; 82:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/88\">",
"      Kelly WF, Kelly MJ, Faragher B. A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol (Oxf) 1996; 45:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/89\">",
"      Heald AH, Ghosh S, Bray S, et al. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clin Endocrinol (Oxf) 2004; 61:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/90\">",
"      Tiemensma J, Biermasz NR, Middelkoop HA, et al. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95:E129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/91\">",
"      Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992; 32:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/92\">",
"      Forget H, Lacroix A, Somma M, Cohen H. Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc. 2000; 6:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/93\">",
"      Starkman MN, Schteingart DE, Schork MA. Correlation of bedside cognitive and neuropsychological tests in patients with Cushing's syndrome. Psychosomatics 1986; 27:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/94\">",
"      Bourdeau I, Bard C, No&euml;l B, et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002; 87:1949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/95\">",
"      Starkman MN, Giordani B, Gebarski SS, Schteingart DE. Improvement in learning associated with increase in hippocampal formation volume. Biol Psychiatry 2003; 53:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/96\">",
"      Tiemensma J, Kokshoorn NE, Biermasz NR, et al. Subtle cognitive impairments in patients with long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95:2699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/97\">",
"      Merke DP, Giedd JN, Keil MF, et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005; 90:2531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/98\">",
"      Hanson JA, Sohaib SA, Newell-Price J, et al. Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome. J Clin Endocrinol Metab 1999; 84:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/99\">",
"      Graham BS, Tucker WS Jr. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984; 101:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/100\">",
"      Sarlis NJ, Chanock SJ, Nieman LK. Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 2000; 85:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/101\">",
"      Kronfol Z, Starkman M, Schteingart DE, et al. Immune regulation in Cushing's syndrome: relationship to hypothalamic-pituitary-adrenal axis hormones. Psychoneuroendocrinology 1996; 21:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/102\">",
"      Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/103\">",
"      Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/104\">",
"      Jilma B, Stohlawetz P, Pernerstorfer T, et al. Glucocorticoids dose-dependently increase plasma levels of granulocyte colony stimulating factor in man. J Clin Endocrinol Metab 1998; 83:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/105\">",
"      Khaw KW, Jalaludin MY, Suhaimi H, et al. Endogenous Cushing syndrome from an ectopic adrenocorticotropic hormone production as a rare cause of ocular hypertension. J AAPOS 2010; 14:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/106\">",
"      Huschle OK, Jonas JB, Koniszewski G, et al. [Glaucoma in central hypothalamic-hypophyseal Cushing syndrome]. Fortschr Ophthalmol 1990; 87:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/107\">",
"      Jonas JB, Huschle O, Koniszewski G, et al. Intraocular pressure in patients with Cushing's disease. Graefes Arch Clin Exp Ophthalmol 1990; 228:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/108\">",
"      Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/48/22282/abstract/109\">",
"      Boumpas DT, Chrousos GP, Wilder RL, et al. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119:1198.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 143 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6F4C19BDB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22282=[""].join("\n");
var outline_f21_48_22282=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H588676213\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H588675336\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H588675624\">",
"      Iatrogenic Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H588675631\">",
"      Ectopic ACTH syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H588675645\">",
"      Cushing's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86477002\">",
"      Adrenal tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H588675861\">",
"      Sex-related incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H588675868\">",
"      Age-related incidence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Progressive obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dermatologic manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Menstrual irregularities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Signs of adrenal androgen excess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Proximal muscle wasting and weakness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Bone loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Subclinical hypercortisolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Glucose intolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hypertension and cardiovascular risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Ectopic ACTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Thromboembolic events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H588675995\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Neuropsychological changes and cognition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H139159262\">",
"      - Cognition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Infection and immune function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Ophthalmologic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Administration of high doses of glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H588676213\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/143\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/143|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/17/43288\" title=\"figure 1\">",
"      Abnormal growth in a child with Cushings disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/143|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/48/35585\" title=\"picture 1\">",
"      Progressive Cushings obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/57/19344\" title=\"picture 2\">",
"      Centripetal obesity in Cushings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/12/9423\" title=\"picture 3\">",
"      Moon facies in Cushings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/22/22886\" title=\"picture 4\">",
"      Buffalo hump in Cushings syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/47/15103\" title=\"picture 5\">",
"      Bruising in Cushings disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/51/6975\" title=\"picture 6\">",
"      Striae in Cushings disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/4/75\" title=\"picture 7A\">",
"      Hyperpigmentation Nelsons syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/8/44161\" title=\"picture 7B\">",
"      Palm hyperpigmentation Nelsons",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/55/25456\" title=\"picture 8\">",
"      Buccal hyperpigmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/48/22273\" title=\"picture 9\">",
"      Pigmented scar in Cushings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/19/38207\" title=\"picture 10\">",
"      Premature puberty in Cushings syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/38/623\" title=\"picture 11\">",
"      Proximal wasting in Cushings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/143|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/39/18044\" title=\"table 1\">",
"      Signs of Cushings syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40838?source=related_link\">",
"      Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=related_link\">",
"      Causes and pathophysiology of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=related_link\">",
"      Clinical presentation and evaluation of adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/45/730?source=related_link\">",
"      Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/35/22072?source=related_link\">",
"      Cushing's syndrome due to primary pigmented nodular adrenocortical disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4725?source=related_link\">",
"      Cushing's syndrome in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31225?source=related_link\">",
"      Establishing the cause of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21913?source=related_link\">",
"      Establishing the diagnosis of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=related_link\">",
"      Glucocorticoid-induced myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=related_link\">",
"      Major side effects of inhaled glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=related_link\">",
"      Osteonecrosis (avascular necrosis of bone)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=related_link\">",
"      Overview of homocysteine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36458?source=related_link\">",
"      Overview of medical care in adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/63/1016?source=related_link\">",
"      Overview of the treatment of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=related_link\">",
"      Pathobiology and staging of small cell carcinoma of the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42855?source=related_link\">",
"      Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/19/13619?source=related_link\">",
"      Patient information: Cushing's syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/61/6099?source=related_link\">",
"      Patient information: Cushing's syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18569?source=related_link\">",
"      The adrenal incidentaloma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_48_22283="Organisms soft tissue infection";
var content_f21_48_22283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75469&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75469&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Organisms associated with soft tissue infection following water exposure",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Organism",
"       </td>",
"       <td class=\"subtitle1\">",
"        Exposure",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aeromonas spp*",
"       </td>",
"       <td>",
"        Fresh water",
"       </td>",
"       <td>",
"        Rapidly developing infection associated with fever; Sepsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Edwardsiella tarda*",
"       </td>",
"       <td>",
"        Fresh water",
"       </td>",
"       <td>",
"        Cellulitis, occasionally, fulminant infection with bacteremia;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erysipelothrix rhusiopathiae",
"       </td>",
"       <td>",
"        Puncture wounds from shrimp, crabs, and fish",
"       </td>",
"       <td>",
"        Indolent localized cutaneous eruption; erysipeloid;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vibrio vulnificus*",
"       </td>",
"       <td>",
"        Salt or brackish water",
"       </td>",
"       <td>",
"        Rapidly progressive necrotizing infection; Bullous cellulitis; Sepsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycobacterium marinum",
"       </td>",
"       <td>",
"        Salt or fresh water including fish tanks",
"       </td>",
"       <td>",
"        Indolent infection; Papules progressing to shallow ulcers; Ascending lesions may resemble sporotrichosis;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Infection associated with patients with underlying liver disease, iron-overload syndromes, and cancer; Infection in these high-risk groups particularly fulminant.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22283=[""].join("\n");
var outline_f21_48_22283=null;
var title_f21_48_22284="Drugs causing coma";
var content_f21_48_22284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Select toxic agents causing coma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Toxic agent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Features which may distinguish from opioids",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antihistamines",
"      </td>",
"      <td>",
"       Anticholinergic toxidrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antipsychotics",
"      </td>",
"      <td>",
"       Pupils, bowel sounds normal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Barbiturates",
"      </td>",
"      <td>",
"       Mild to severe hypotension, serum concentration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &beta;-adrenergic antagonists",
"      </td>",
"      <td>",
"       Cardiovascular findings (hypotension, bradycardia) more prominent than mental status findings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Calcium channel blockers",
"      </td>",
"      <td>",
"       Cardiovascular findings (hypotension, bradycardia, or tachycardia) more prominent than mental status findings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbamazepine",
"      </td>",
"      <td>",
"       Serum concentration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbon monoxide",
"      </td>",
"      <td>",
"       Carboxyhemoglobin level",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clonidine",
"      </td>",
"      <td>",
"       Bradycardia, hypotension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cyclic antidepressants",
"      </td>",
"      <td>",
"       QRS prolongation, hypotension, tachycardia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ethanol",
"      </td>",
"      <td>",
"       Pupils, bowel sounds normal, serum concentration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ethylene glycol",
"      </td>",
"      <td>",
"       Pupils, bowel sounds normal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypoglycemic agents",
"      </td>",
"      <td>",
"       Serum glucose concentration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Isoniazid",
"      </td>",
"      <td>",
"       History of seizures, normal pupils, bowel sounds",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Isopropanol",
"      </td>",
"      <td>",
"       Pupils, bowel sounds normal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lithium",
"      </td>",
"      <td>",
"       Tremor, hyperreflexia, serum concentration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Methanol",
"      </td>",
"      <td>",
"       Pupils, bowel sounds normal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Organic-phosphorous compounds",
"      </td>",
"      <td>",
"       Cholinergic toxidrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phencyclidine",
"      </td>",
"      <td>",
"       Nystagmus (horizontal, vertical, or rotary)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sedative-hypnotic agents",
"      </td>",
"      <td>",
"       Pupil size normal to decreased, bowel sounds normal, less respiratory depression",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22284=[""].join("\n");
var outline_f21_48_22284=null;
var title_f21_48_22285="Homocysteine carotid stenosis";
var content_f21_48_22285=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Homocysteine and carotid stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 249px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Age-adjusted prevalence of extracranial carotid artery stenosis (&gt;25 percent) in 1041 elderly men and women in the Framingham Heart Study according to the plasma homocysteine concentration. The trends toward a higher frequency of carotid stenosis at increasing homocysteine levels was statistically significant. The individual data points represent the different quartiles for homocysteine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Selhub, J, Jacques, PF, Bostom, AG, et al, N Engl J Med 1995; 332:286.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22285=[""].join("\n");
var outline_f21_48_22285=null;
var title_f21_48_22286="Stroke rates asymptomatic CAS";
var content_f21_48_22286=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F82860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F82860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 599px\">",
"   <div class=\"ttl\">",
"    Average annual stroke rates in medically-treated patients with asymptomatic carotid stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 579px; height: 344px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Naylor AR. What is the current status of invasive treatment of extracranial carotid artery disease? Stroke 2011; 42:2080. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22286=[""].join("\n");
var outline_f21_48_22286=null;
var title_f21_48_22287="Corneal perforation";
var content_f21_48_22287=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Corneal perforation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Demonstrated by fluorescein flow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_48_22287=[""].join("\n");
var outline_f21_48_22287=null;
